Browse by UCL Departments and Centres
![[up]](/style/images/multi_up.png)
Up a levelGroup by: Author | Type
Number of items: 429.
A
Adams-Carr, KL;
Bocchetta, M;
Neason, M;
Holton, JL;
Lashley, T;
Warren, JD;
Rohrer, JD;
(2020)
A case of TDP-43 type C pathology presenting as nonfluent variant primary progressive aphasia.
Neurocase
, 26
(1)
pp. 1-6.
10.1080/13554794.2019.1690665.
|
|
Alić, I;
Goh, PA;
Murray, A;
Portelius, E;
Gkanatsiou, E;
Gough, G;
Mok, KY;
... Nižetić, D; + view all
(2020)
Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain.
Molecular Psychiatry
10.1038/s41380-020-0806-5.
|
 |
|
Alifier, M;
Olsson, B;
Andreasson, U;
Cullen, NC;
Czyżewska, J;
Jakubów, P;
Sieśkiewicz, A;
... Blennow, K; + view all
(2020)
Cardiac Surgery is Associated with Biomarker Evidence of Neuronal Damage.
Journal of Alzheimer's Disease
10.3233/JAD-191165.
(In press).
|
|
|
Alonso-Canovas, A;
Alvarez Velasco, R;
Giraldo, P;
Irun, P;
Vela Desojo, L;
Lopez Manzanares, L;
Arbelo Gonzalez, JM;
... Martinez Castrillo, JC; + view all
(2020)
Glucocerebrosidase activity and atypical parkinsonism: a multi-centre exploratory study.
Presented at: Movement-Disorder-Society (MDS) International Virtual Congress.
|
|
Altmann, A;
Cash, DM;
Bocchetta, M;
Heller, C;
Reynolds, R;
Moore, K;
Convery, RS;
... Rohrer, JD; + view all
(2020)
Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia.
Brain Communications
10.1093/braincomms/fcaa122.
(In press).
|
|
|
Altmann, A;
Scelsi, M;
Shoai, M;
De Silva, E;
Aksman, L;
Cash, D;
Hardy, J;
(2020)
A comprehensive analysis of methods for assessing polygenic burden on Alzheimer’s disease pathology and risk beyond APOE.
Brain Communications
, 2
(1)
, Article fcz047. 10.1093/braincomms/fcz047.
|
|
|
Altmann, P;
De Simoni, D;
Kaider, A;
Ludwig, B;
Rath, J;
Leutmezer, F;
Zimprich, F;
... Rommer, PS; + view all
(2020)
Increased serum neurofilament light chain concentration indicates poor outcome in Guillain-Barré syndrome.
Journal of Neuroinflammation
, 17
, Article 86. 10.1186/s12974-020-01737-0.
|
|
|
Altmann, P;
Leutmezer, F;
Zach, H;
Wurm, R;
Stattmann, M;
Ponleitner, M;
Petzold, A;
... Bsteh, G; + view all
(2020)
Serum neurofilament light chain withstands delayed freezing and repeated thawing.
Scientific Reports
, 10
, Article 19982. 10.1038/s41598-020-77098-8.
|
|
|
Anderson, AM;
Jang, JH;
Easley, KA;
Fuchs, D;
Gisslen, M;
Zetterberg, H;
Blennow, K;
... Letendre, SL; + view all
(2020)
Cognitive and Neuronal Link With Inflammation: A Longitudinal Study in People With and Without HIV Infection.
JAIDS: Journal of Acquired Immune Deficiency Syndromes
, 85
(5)
pp. 617-625.
10.1097/QAI.0000000000002484.
|
|
Andersson, E;
Janelidze, S;
Lampinen, B;
Nilsson, M;
Leuzy, A;
Stomrud, E;
Blennow, K;
... Hansson, O; + view all
(2020)
Blood and cerebrospinal fluid neurofilament light differentially detect neurodegeneration in early Alzheimer's disease.
Neurobiology of Aging
, 95
pp. 143-153.
10.1016/j.neurobiolaging.2020.07.018.
(In press).
|
|
|
Andrews, SC;
Langbehn, DR;
Craufurd, D;
Durr, A;
Leavitt, BR;
Roos, RA;
Tabrizi, SJ;
... TRACK-HD Investigators; + view all
(2020)
Apathy predicts rate of cognitive decline over 24 months in premanifest Huntington's disease.
Psychological Medicine
10.1017/S0033291720000094.
(In press).
|
|
Antonell, A;
Tort-Merino, A;
Ríos, J;
Balasa, M;
Borrego-Écija, S;
Auge, JM;
Muñoz-García, C;
... Sánchez-Valle, R; + view all
(2020)
Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias.
Alzheimer's & Dementia
, 16
(2)
pp. 262-272.
10.1016/j.jalz.2019.09.001.
|
|
Arber, C;
Toombs, J;
Lovejoy, C;
Ryan, NS;
Paterson, RW;
Willumsen, N;
Gkanatsiou, E;
... Wray, S; + view all
(2020)
Familial Alzheimer’s disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta.
Molecular Psychiatry
, 25
pp. 2919-2931.
10.1038/s41380-019-0410-8.
|
|
Arenaza-Urquijo Em, EM;
Salvadó, G;
Operto, G;
Minguillón, C;
Sánchez-Benavides, G;
Crous-Bou, M;
Grau-Rivera, O;
... ALFA study, .; + view all
(2020)
Association of years to parent's sporadic onset and risk factors with neural integrity and Alzheimer's biomarkers.
Neurology
, 95
(15)
e2065-e2074.
10.1212/WNL.0000000000010527.
|
|
Asante, EA;
Linehan, JM;
Tomlinson, AD;
Jakubcova, T;
Hamdan, S;
Grimshaw, A;
Smidak, M;
... Collinge, J; + view all
(2020)
Spontaneous generation of prions and transmissible PrP amyloid in a humanised transgenic mouse model of A117V GSS.
PLOS Biology
, 18
(6)
, Article e3000725. 10.1371/journal.pbio.3000725.
|
|
|
Asher, DM;
Belay, E;
Bigio, E;
Brandner, S;
Brubaker, SA;
Caughey, B;
Clark, B;
... Frosch, MP; + view all
(2020)
Risk of Transmissibility From Neurodegenerative Disease-Associated Proteins: Experimental Knowns and Unknowns.
Journal of Neuropathology & Experimental Neurology
10.1093/jnen/nlaa109.
(In press).
|
|
|
Ashton, NJ;
Hye, A;
Rajkumar, AP;
Leuzy, A;
Snowden, S;
Suarez-Calvet, M;
Karikari, TK;
... Aarsland, D; + view all
(2020)
An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders.
Nature Reviews Neurology
, 16
(5)
pp. 265-284.
10.1038/s41582-020-0348-0.
|
B
|
Bäckström, D;
Linder, J;
Mo, SJ;
Riklund, K;
Zetterberg, H;
Blennow, K;
Forsgren, L;
(2020)
NfL as a biomarker for neurodegeneration and survival in Parkinson disease.
Neurology
10.1212/WNL.0000000000010084.
(In press).
|
|
|
Bader, JM;
Geyer, PE;
Müller, JB;
Strauss, MT;
Koch, M;
Leypoldt, F;
Koertvelyessy, P;
... Mann, M; + view all
(2020)
Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease.
Molecular Systems Biology
, 16
(6)
, Article e9356. 10.15252/msb.20199356.
|
|
|
Baldacci, F;
Lista, S;
Manca, ML;
Chiesa, PA;
Cavedo, E;
Lemercier, P;
Zetterberg, H;
... Alzheimer Precision Medicine Initiative (APMI), .; + view all
(2020)
Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study.
Alzheimer's Research & Therapy
, 12
(1)
, Article 147. 10.1186/s13195-020-00704-4.
|
|
|
Balint, B;
Guerreiro, R;
Carmona, S;
Dehghani, N;
Latorre, A;
Cordivari, C;
Bhatia, KP;
(2020)
KCNN2 mutation in autosomal-dominant tremulous myoclonus-dystonia.
European Journal of Neurology
, 27
(8)
pp. 1471-1477.
10.1111/ene.14228.
|
|
Ball, HA;
McWhirter, L;
Ballard, C;
Bhome, R;
Blackburn, DJ;
Edwards, MJ;
Fleming, SM;
... Carson, AJ; + view all
(2020)
Functional cognitive disorder: dementia's blind spot.
Brain
, 143
(10)
pp. 2895-2903.
10.1093/brain/awaa224.
|
|
Bampton, A;
Gittings, LM;
Fratta, P;
Lashley, T;
Gatt, A;
(2020)
The role of hnRNPs in frontotemporal dementia and amyotrophic lateral sclerosis.
Acta Neuropathologica
10.1007/s00401-020-02203-0.
(In press).
|
|
|
Banerjee, G;
Ambler, G;
Keshavan, A;
Paterson, RW;
Foiani, MS;
Toombs, J;
Heslegrave, A;
... Werring, DJ; + view all
(2020)
Cerebrospinal fluid biomarkers in cerebral amyloid angiopathy.
Journal of Alzheimer's Disease
, 74
(4)
pp. 1189-1201.
10.3233/JAD-191254.
(In press).
|
|
Banote, RK;
Chebli, J;
Şatır, TM;
Varshney, GK;
Camacho, R;
Ledin, J;
Burgess, SM;
... Zetterberg, H; + view all
(2020)
Amyloid precursor protein-b facilitates cell adhesion during early development in zebrafish.
Scientific Reports
, 10
, Article 10127. 10.1038/s41598-020-66584-8.
|
|
|
Barbu, M;
Kolsrud, O;
Ricksten, S-E;
Dellgren, G;
Zetterberg, H;
Blennow, K;
Björk, K;
... Jeppsson, A; + view all
(2020)
Dextran- Versus Crystalloid-Based Prime in Cardiac Surgery: A Prospective Randomized Pilot Study.
The Annals of Thoracic Surgery
, 110
(5)
pp. 1541-1547.
10.1016/j.athoracsur.2020.03.031.
|
|
Barthelemy, NR;
Li, Y;
Joseph-Mathurin, N;
Gordon, BA;
Hassenstab, J;
Benzinger, TLS;
Buckles, V;
... Xu, X; + view all
(2020)
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease.
Nature Medicine
, 26
(3)
pp. 398-407.
10.1038/s41591-020-0781-z.
|
|
Bartolome, F;
Krzyzanowska, A;
de la Cueva, M;
Pascual, C;
Antequera, D;
Spuch, C;
Villarejo-Galende, A;
... Carro, E; + view all
(2020)
Annexin A5 prevents amyloid-β-induced toxicity in choroid plexus: implication for Alzheimer’s disease.
Scientific Reports
, 10
, Article 9391. 10.1038/s41598-020-66177-5.
|
|
|
Bauermeister, S;
Orton, C;
Thompson, S;
Barker, RA;
Bauermeister, JR;
Ben-Shlomo, Y;
Brayne, C;
... Gallacher, JEJ; + view all
(2020)
The Dementias Platform UK (DPUK) Data Portal.
European Journal of Epidemiology
10.1007/s10654-020-00633-4.
(In press).
|
|
Beale, S;
Johnson, AM;
Zambon, M;
Hayward, AC;
Fragaszy, EB;
(2020)
Hand Hygiene Practices and the Risk of Human Coronavirus Infections in a UK Community Cohort [version 1; peer review: awaiting peer review].
Wellcome Open Research
, 5
, Article 98. 10.12688/wellcomeopenres.15796.1.
|
|
|
Bellio, M;
Oxtoby, NP;
Walker, Z;
Henley, S;
Ribbens, A;
Blandford, A;
Alexander, DC;
(2020)
Analyzing large Alzheimer’s disease cognitive datasets: Considerations and challenges.
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
, 12
(1)
, Article e12135. 10.1002/dad2.12135.
|
|
|
Belsten, J;
Werring, DJ;
Jones, H;
Heales, S;
Pope, S;
(2020)
Cerebrospinal fluid folate, ascorbate, and tetrahydrobiopterin deficiency in superficial siderosis: A new potential mechanism of neurological dysfunction?
Journal of the Neurological Sciences
, 414
, Article 116856. 10.1016/j.jns.2020.116856.
|
|
Benedet, AL;
Leuzy, A;
Pascoal, TA;
Ashton, NJ;
Mathotaarachchi, S;
Savard, M;
Therriault, J;
... Alzheimer’s Disease Neuroimaging Initiative, .; + view all
(2020)
Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
Brain
, 143
(12)
pp. 3793-3804.
10.1093/brain/awaa342.
|
|
Benedict, C;
Blennow, K;
Zetterberg, H;
Cedernaes, J;
(2020)
Effects of acute sleep loss on diurnal plasma dynamics of CNS health biomarkers in young men.
Neurology
10.1212/WNL.0000000000008866.
(In press).
|
|
|
Benhamou, E;
Marshall, CR;
Russell, LL;
Hardy, CJD;
Bond, RL;
Sivasathiaseelan, H;
Greaves, CV;
... Razi, A; + view all
(2020)
The neurophysiological architecture of semantic dementia: spectral dynamic causal modelling of a neurodegenerative proteinopathy.
Scientific Reports
, 10
, Article 16321. 10.1038/s41598-020-72847-1.
|
|
|
Benussi, A;
Ashton, NJ;
Karikari, TK;
Gazzina, S;
Premi, E;
Benussi, L;
Ghidoni, R;
... Borroni, B; + view all
(2020)
Serum Glial Fibrillary Acidic Protein (GFAP) Is a Marker of Disease Severity in Frontotemporal Lobar Degeneration.
Journal of Alzheimer's Disease
10.3233/JAD-200608.
(In press).
|
|
|
Benussi, A;
Karikari, TK;
Ashton, N;
Gazzina, S;
Premi, E;
Benussi, L;
Ghidoni, R;
... Borroni, B; + view all
(2020)
Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration.
Journal of Neurology, Neurosurgery, and Psychiatry
, 91
(9)
pp. 960-967.
10.1136/jnnp-2020-323487.
|
|
|
Bettencourt, C;
Foti, SC;
Miki, Y;
Botia, J;
Chatterjee, A;
Warner, TT;
Revesz, T;
... Holton, JL; + view all
(2020)
White matter DNA methylation profiling reveals deregulation of HIP1, LMAN2, MOBP, and other loci in multiple system atrophy.
Acta Neuropathologica
, 139
pp. 135-156.
10.1007/s00401-019-02074-0.
|
|
|
Bettencourt, C;
Piras, IS;
Foti, SC;
Talboom, J;
Miki, Y;
Lashley, T;
Balazs, R;
... Holton, JL; + view all
(2020)
Epigenomics and transcriptomics analyses of multiple system atrophy brain tissue supports a role for inflammatory processes in disease pathogenesis.
Acta Neuropathologica Communications
, 8
, Article 71. 10.1186/s40478-020-00946-1.
|
|
|
Billot, B;
Bocchetta, M;
Todd, E;
Dalca, AV;
Rohrer, JD;
Iglesias, JE;
(2020)
Automated segmentation of the Hypothalamus and associated subunits in brain MRI.
NeuroImage
, 223
, Article 117287. 10.1016/j.neuroimage.2020.117287.
(In press).
|
|
|
Bjorefeldt, A;
Roshan, F;
Forsberg, M;
Zetterberg, H;
Hanse, E;
Fisahn, A;
(2020)
Human cerebrospinal fluid promotes spontaneous gamma oscillations in the hippocampus in vitro.
Hippocampus
, 30
(2)
pp. 101-113.
10.1002/hipo.23135.
|
|
Blauwendraat, C;
Reed, X;
Krohn, L;
Heilbron, K;
Bandres-Ciga, S;
Tan, M;
Gibbs, JR;
... Singleton, AB; + view all
(2020)
Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia.
Brain
, 143
(1)
pp. 234-248.
10.1093/brain/awz350.
|
|
Blenkinsop, A;
van der Flier, WM;
Wolk, D;
Lehmann, M;
Howard, R;
Frost, C;
Barnes, J;
(2020)
Non-memory cognitive symptom development in Alzheimer's disease.
European Journal of Neurology
, 27
(6)
pp. 995-1002.
10.1111/ene.14185.
|
|
Blennow, K;
Chen, C;
Cicognola, C;
Wildsmith, KR;
Manser, PT;
Bohorquez, SMS;
Zhang, Z;
... Höglund, K; + view all
(2020)
Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology.
Brain
, 143
(2)
, Article 79. 10.1093/brain/awz346.
|
|
Bloniecki, V;
Zetterberg, H;
Aarsland, D;
Vannini, P;
Kvartsberg, H;
Winblad, B;
Blennow, K;
(2020)
Are neuropsychiatric symptoms in dementia linked to CSF biomarkers of synaptic and axonal degeneration?
Alzheimer's Research and Therapy
, 12
(1)
, Article 153. 10.1186/s13195-020-00718-y.
|
|
|
Bocchetta, M;
Iglesias, JE;
Neason, M;
Cash, DM;
Warren, JD;
Rohrer, JD;
(2020)
Thalamic nuclei in frontotemporal dementia: Mediodorsal nucleus involvement is universal but pulvinar atrophy is unique to C9orf72.
Human Brain Mapping
, 41
(4)
pp. 1006-1016.
10.1002/hbm.24856.
|
|
|
Bocchetta, M;
Iglesias Espinosa, MDM;
Lashley, T;
Warren, JD;
Rohrer, JD;
(2020)
In vivo staging of frontotemporal lobar degeneration TDP-43 type C pathology.
Alzheimer's Research & Therapy
, 12
(1)
, Article 34. 10.1186/s13195-020-00600-x.
|
|
|
Bodda, C;
Reinert, LS;
Fruhwürth, S;
Richardo, T;
Sun, C;
Zhang, B-C;
Kalamvoki, M;
... Paludan, SR; + view all
(2020)
HSV1 VP1-2 deubiquitinates STING to block type I interferon expression and promote brain infection.
Journal of Experimental Medicine
, 217
(7)
, Article e20191422. 10.1084/jem.20191422.
|
|
|
Bödör, C;
Alpár, D;
Marosvári, D;
Galik, B;
Rajnai, H;
Bátai, B;
Nagy, Á;
... PharmD; + view all
(2020)
Molecular Subtypes and Genomic Profile of Primary Central Nervous System Lymphoma.
Journal of Neuropathology & Experimental Neurology
, 79
(2)
pp. 176-183.
10.1093/jnen/nlz125.
|
|
Boulo, S;
Kuhlmann, J;
Andreasson, U;
Brix, B;
Venkataraman, I;
Herbst, V;
Rutz, S;
... Blennow, K; + view all
(2020)
First amyloid β1-42 certified reference material for re-calibrating commercial immunoassays.
Alzheimer's & Dementia
, 16
(11)
pp. 1493-1503.
10.1002/alz.12145.
|
|
|
Boxer, AL;
Gold, M;
Feldman, H;
Boeve, BF;
Dickinson, SL-J;
Fillit, H;
Ho, C;
... Tatton, N; + view all
(2020)
New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures.
Alzheimer's & Dementia
, 16
(1)
pp. 131-143.
10.1016/j.jalz.2019.06.4956.
|
|
Breakell, T;
Tacke, S;
Schropp, V;
Zetterberg, H;
Blennow, K;
Urich, E;
Kuerten, S;
(2020)
Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis.
International Journal of Molecular Sciences
, 21
(18)
, Article 6864. 10.3390/ijms21186864.
|
|
|
Brogueira Rodrigues, F;
Byrne, L;
Tortelli, R;
Johnson, E;
Wijeratne, P;
De Vita, E;
Ghazaleh, N;
... Wild, E; + view all
(2020)
Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington's disease.
Science Translational Medicine
, 12
(574)
10.1126/scitranslmed.abc2888.
|
|
|
Brotherhood, EV;
Stott, J;
Windle, G;
Barker, S;
Culley, S;
Harding, E;
Camic, PM;
... Crutch, SJ; + view all
(2020)
Protocol for the Rare Dementia Support Impact Study: RDS Impact.
International Journal of Geriatric Psychiatry
10.1002/gps.5253.
(In press).
|
|
|
Brown, EE;
Blauwendraat, C;
Trinh, J;
Rizig, M;
Nalls, MA;
Leveille, E;
Ruskey, JA;
... International Parkinson Disease Genomics Consortium (IPDGC); + view all
(2020)
Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson’s disease.
Neurobiology of Aging
10.1016/j.neurobiolaging.2020.07.002.
(In press).
|
|
|
Buchanan, SM;
Parker, TD;
Lane, CA;
Keshavan, A;
Keuss, SE;
Lu, K;
James, S-N;
... Schott, JM; + view all
(2020)
Olfactory testing does not predict beta-amyloid, MRI measures of neurodegeneration or vascular pathology in the British 1946 birth cohort.
Journal of Neurology
10.1007/s00415-020-10004-4.
(In press).
|
|
|
Byrne, Lauren Mary;
(2020)
Development of biofluid biomarkers for Huntington’s disease.
Doctoral thesis (Ph.D), UCL (University College London).
|
C
|
C Dabin, L;
Guntoro, F;
Campbell, T;
Bélicard, T;
Smith, AR;
Smith, RG;
Raybould, R;
... Viré, E; + view all
(2020)
Altered DNA methylation profiles in blood from patients with sporadic Creutzfeldt–Jakob disease.
Acta Neuropathologica
10.1007/s00401-020-02224-9.
(In press).
|
|
|
Cacciaglia, R;
Molinuevo, JL;
Falcón, C;
Arenaza-Urquijo, EM;
Sánchez-Benavides, G;
Brugulat-Serrat, A;
Blennow, K;
... ALFA study; + view all
(2020)
APOE-ε4 Shapes the Cerebral Organization in Cognitively Intact Individuals as Reflected by Structural Gray Matter Networks.
Cerebral Cortex
10.1093/cercor/bhaa034.
(In press).
|
|
|
Caciagli, L;
Wandschneider, B;
Centeno, M;
Vollmar, C;
Vos, SB;
Trimmel, K;
Long, L;
... Koepp, MJ; + view all
(2020)
Motor hyperactivation during cognitive tasks: An endophenotype of juvenile myoclonic epilepsy.
Epilepsia
10.1111/epi.16575.
(In press).
|
|
|
Camporesi, E;
Nilsson, J;
Brinkmalm, A;
Becker, B;
Ashton, NJ;
Blennow, K;
Zetterberg, H;
(2020)
Fluid Biomarkers for Synaptic Dysfunction and Loss.
Biomarker Insights
, 15
10.1177/1177271920950319.
|
|
|
Camu, W;
Mickunas, M;
Veyrune, J-L;
Payan, C;
Garlanda, C;
Locati, M;
Juntas-Morales, R;
... Bensimon, G; + view all
(2020)
Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial.
EBioMedicine
, Article 102844. 10.1016/j.ebiom.2020.102844.
(In press).
|
|
|
Casey, CP;
Lindroth, H;
Mohanty, R;
Farahbakhsh, Z;
Ballweg, T;
Twadell, S;
Miller, S;
... Sanders, RD; + view all
(2020)
Postoperative delirium is associated with increased plasma neurofilament light.
Brain
, 143
(1)
pp. 47-54.
10.1093/brain/awz354.
|
|
Cavedo, E;
Lista, S;
Houot, M;
Vergallo, A;
Grothe, MJ;
Teipel, S;
Zetterberg, H;
... INSIGHT-preAD Study Group and the Alzheimer Precision Medicine I; + view all
(2020)
Plasma tau correlates with basal forebrain atrophy rates in people at risk for Alzheimer disease.
Neurology
, 94
(1)
e30-e41.
10.1212/WNL.0000000000008696.
|
|
Chang, P;
Bush, D;
Schorge, S;
Good, M;
Canonica, T;
Shing, N;
Noy, S;
... Fisher, EMC; + view all
(2020)
Altered Hippocampal-Prefrontal Neural Dynamics in Mouse Models of Down Syndrome.
Cell Reports
, 30
(4)
1152-1163.e4.
10.1016/j.celrep.2019.12.065.
|
|
|
Chatterjee, P;
Cheong, Y-J;
Bhatnagar, A;
Goozee, K;
Wu, Y;
McKay, M;
Martins, IJ;
... Martins, RN; + view all
(2020)
Plasma metabolites associated with biomarker evidence of neurodegeneration in cognitively normal older adults.
Journal of Neurochemistry
, 159
(2)
pp. 389-402.
10.1111/jnc.15128.
|
|
Chatterjee, P;
Mohammadi, M;
Goozee, K;
Shah, TM;
Sohrabi, HR;
Dias, CB;
Shen, K;
... Martins, RN; + view all
(2020)
Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load.
Journal of Alzheimer's Disease
, 76
(1)
pp. 291-301.
10.3233/JAD-200162.
|
|
|
Chaudhary, H;
Meister, SW;
Zetterberg, H;
Löfblom, J;
Lendel, C;
(2020)
Dissecting the structural organization of multiprotein amyloid aggregates using a bottom-up approach.
ACS Chemical Neuroscience
10.1021/acschemneuro.0c00110.
(In press).
|
|
|
Chen, CCL;
Deshmukh, S;
Jessa, S;
Hadjadj, D;
Lisi, V;
Andrade, AF;
Faury, D;
... Jabado, N; + view all
(2020)
Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis.
Cell
, 183
(6)
1617-1633.e22.
10.1016/j.cell.2020.11.012.
|
|
Chen, Z;
Ryten, M;
Houlden, H;
(2020)
Reply to: No evidence supports genetic heterogeneity of neuronal intranuclear inclusion disease.
Annals of Clinical and Translational Neurology
, 7
(12)
pp. 2544-2545.
10.1002/acn3.51222.
|
|
Chen, Z;
Yan Yau, W;
Jaunmuktane, Z;
Tucci, A;
Sivakumar, P;
Gagliano Taliun, SA;
Turner, C;
... Houlden, H; + view all
(2020)
Neuronal intranuclear inclusion disease is genetically heterogeneous.
Annals of Clinical and Translational Neurology
, 7
(9)
pp. 1716-1725.
10.1002/acn3.51151.
|
|
Chételat, G;
Arbizu, J;
Barthel, H;
Garibotto, V;
Law, I;
Morbelli, S;
van de Giessen, E;
... Drzezga, A; + view all
(2020)
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias.
The Lancet Neurology
, 19
(11)
pp. 951-962.
10.1016/S1474-4422(20)30314-8.
|
|
Chiesa, PA;
Houot, M;
Vergallo, A;
Cavedo, E;
Lista, S;
Potier, MC;
Zetterberg, H;
... Alzheimer Precision Medicine Initiative (APMI); + view all
(2020)
Association of brain network dynamics with plasma biomarkers in subjective memory complainers.
Neurobiology of Aging
, 88
pp. 83-90.
10.1016/j.neurobiolaging.2019.12.017.
|
|
Cicognola, C;
Satir, TM;
Brinkmalm, G;
Matečko-Burmann, I;
Agholme, L;
Bergström, P;
Becker, B;
... Höglund, K; + view all
(2020)
Tauopathy-Associated Tau Fragment Ending at Amino Acid 224 Is Generated by Calpain-2 Cleavage.
Journal of Alzheimer's Disease
10.3233/JAD-191130.
(In press).
|
|
|
Clark, CN;
Quaegebeur, A;
Nirmalananthan, N;
MacKinnon, AD;
Revesz, T;
Holton, JL;
Bridges, LR;
(2020)
Foix–Chavany–Marie syndrome due to type E TDP43 pathology.
Neuropathology and Applied Neurobiology
, 46
(3)
pp. 292-295.
10.1111/nan.12579.
|
|
Clayton, EL;
Isaacs, AM;
(2020)
Progranulin and TMEM106B: when two become wan.
EMBO Reports
, 21
(10)
, Article e51668. 10.15252/embr.202051668.
|
|
|
Collins, JD;
Henley, SMD;
Suárez-González, A;
(2020)
A systematic review of the prevalence of depression, anxiety, and apathy in frontotemporal dementia, atypical and young-onset Alzheimer's disease, and inherited dementia.
International Psychogeriatrics
10.1017/S1041610220001118.
(In press).
|
|
Colom-Cadena, M;
Spires-Jones, T;
Zetterberg, H;
Blennow, K;
Caggiano, A;
DeKosky, ST;
Fillit, H;
... Catalano, SM; + view all
(2020)
The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease.
ALZHEIMERS RESEARCH & THERAPY
, 12
(1)
10.1186/s13195-020-00588-4.
|
|
Compta, Y;
Revesz, T;
(2020)
Neuropathological and Biomarker Findings in Parkinson's Disease and Alzheimer's Disease: From Protein Aggregates to Synaptic Dysfunction.
Journal of Parkinson's Disease
10.3233/JPD-202323.
(In press).
|
|
|
Convery, RS;
Bocchetta, M;
Greaves, CV;
Moore, KM;
Cash, DM;
Van Swieten, J;
Moreno, F;
... Genetic FTD Initiative (GENFI); + view all
(2020)
Abnormal pain perception is associated with thalamo-cortico-striatal atrophy in C9orf72 expansion carriers in the GENFI cohort.
Journal of Neurology, Neurosurgery, and Psychiatry
10.1136/jnnp-2020-323279.
(In press).
|
|
Convery, RS;
Neason, MR;
Cash, DM;
Cardoso, MJ;
Modat, M;
Ourselin, S;
Warren, JD;
... Bocchetta, M; + view all
(2020)
Basal forebrain atrophy in frontotemporal dementia.
NeuroImage: Clinical
, 26
, Article 102210. 10.1016/j.nicl.2020.102210.
|
|
|
Costa, B;
Manzoni, C;
Bernal-Quiros, M;
Kia, D;
Aguilar, M;
Alvarez, I;
Alvarez, V;
... Hardy, J; + view all
(2020)
C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts.
Neurology
, 95
(24)
e3288-e3302.
10.1212/WNL.0000000000010914.
|
|
Cottone, L;
Eden, N;
Usher, I;
Lombard, P;
Ye, H;
Ligammari, L;
Lindsay, D;
... Flanagan, AM; + view all
(2020)
Frequent alterations in p16/CDKN2A identified by immunohistochemistry and FISH in chordoma.
Journal Of Pathology Clinical Research
, 6
(2)
pp. 113-123.
10.1002/cjp2.156.
|
|
|
Crutch, S;
Herron, D;
Pickett, J;
Rosser, S;
Rossor, M;
(2020)
Inspired by chance: valuing patients' informal contributions to research.
The British Medical Journal
, 371
, Article m4478. 10.1136/bmj.m4478.
|
|
|
Cullen, NC;
Zetterberg, H;
Insel, PS;
Olsson, B;
Andreasson, U;
Blennow, K;
Hansson, O;
(2020)
Comparing progression biomarkers in clinical trials of early Alzheimer’s disease.
Annals of Clinical and Translational Neurology
10.1002/acn3.51158.
|
|
D
|
D'Souza, H;
Mason, L;
Mok, KY;
Startin, CM;
Hamburg, S;
Hithersay, R;
Baksh, RA;
... London Down Syndrome (LonDownS) Consortium; + view all
(2020)
Differential Associations of Apolipoprotein E ε4 Genotype With Attentional Abilities Across the Life Span of Individuals With Down Syndrome.
JAMA Network Open
, 3
(9)
, Article e2018221. 10.1001/jamanetworkopen.2020.18221.
|
|
|
Daniel Lai, LL;
Crutch, SJ;
West, J;
Harding, E;
Brotherhood, EV;
Takhar, R;
Firth, N;
(2020)
Development of the Video Analysis Scale of Engagement (VASE) for people with advanced dementia [version 1; peer review: awaiting peer review].
Wellcome Open Research
, 5
, Article 230. 10.12688/wellcomeopenres.16189.1.
|
|
|
Danielson, M;
Wiklund, A;
Granath, F;
Blennow, K;
Mkrtchian, S;
Nellgård, B;
Oras, J;
... Eriksson, LI; + view all
(2020)
Association between cerebrospinal fluid biomarkers of neuronal injury or amyloidosis and cognitive decline after major surgery.
British Journal of Anaesthesia
10.1016/j.bja.2020.09.043.
(In press).
|
|
|
Danielson, M;
Wiklund, A;
Granath, F;
Blennow, K;
Mkrtchian, S;
Nellgård, B;
Oras, J;
... Eriksson, LI; + view all
(2020)
Neuroinflammatory markers associate with cognitive decline after major surgery: findings of an explorative study.
Annals of Neurology
10.1002/ana.25678.
(In press).
|
|
|
Daunt, P;
Ballard, CG;
Creese, B;
Davidson, G;
Hardy, J;
Oshota, O;
Pither, RJ;
(2020)
Polygenic Risk Scoring is an Effective Approach to Predict Those Individuals Most Likely to Decline Cognitively Due to Alzheimer’s Disease.
Journal of Prevention of Alzheimer's Disease
10.14283/jpad.2020.64.
|
|
|
De Pablo-Fernández, E;
González-Herrero, B;
Cerdán Santacruz, D;
Rossor, MN;
Schott, JM;
Lashley, T;
Holton, JL;
... Warner, TT; + view all
(2020)
A Clinicopathologic Study of Movement Disorders in Frontotemporal Lobar Degeneration.
Movement Disorders
10.1002/mds.28356.
(In press).
|
|
De Scheerder, M-A;
Van Hecke, C;
Zetterberg, H;
Fuchs, D;
De Langhe, N;
Rutsaert, S;
Vrancken, B;
... Vandekerckhove, L; + view all
(2020)
Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption.
Journal of Antimicrobial Chemotherapy
, 75
(5)
pp. 1311-1320.
10.1093/jac/dkaa003.
|
|
Degenhardt, K;
Wagner, J;
Skodras, A;
Candlish, M;
Koppelmann, AJ;
Wild, K;
Maxwell, R;
... Neher, JJ; + view all
(2020)
Medin aggregation causes cerebrovascular dysfunction in aging wild-type mice.
Proceedings of the National Academy of Sciences of the United States of America
, 117
(38)
pp. 23925-23931.
10.1073/pnas.2011133117.
|
|
Deiner, S;
Baxter, MG;
Mincer, JS;
Sano, M;
Hall, J;
Mohammed, I;
O'Bryant, S;
... Eckenhoff, R; + view all
(2020)
Human plasma biomarker responses to inhalational general anaesthesia without surgery.
British Journal of Anaesthesia
, 125
(3)
pp. 282-290.
10.1016/j.bja.2020.04.085.
|
|
Delsing, L;
Herland, A;
Falk, A;
Hicks, R;
Synnergren, J;
Zetterberg, H;
(2020)
Models of the blood-brain barrier using iPSC-derived cells.
Molecular and Cellular Neuroscience
, 107
, Article 103533. 10.1016/j.mcn.2020.103533.
|
|
|
Dhiman, K;
Gupta, VB;
Villemagne, VL;
Eratne, D;
Graham, PL;
Fowler, C;
Bourgeat, P;
... Martins, RN; + view all
(2020)
Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease.
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
, 12
(1)
10.1002/dad2.12005.
|
|
|
Dickstein, DL;
De Gasperi, R;
Gama Sosa, MA;
Perez-Garcia, G;
Short, JA;
Sosa, H;
Perez, GM;
... Elder, GA; + view all
(2020)
Brain and blood biomarkers of tauopathy and neuronal injury in humans and rats with neurobehavioral syndromes following blast exposure.
Molecular Psychiatry
10.1038/s41380-020-0674-z.
(In press).
|
|
Dincer, A;
Gordon, BA;
Hari-Raj, A;
Keefe, SJ;
Flores, S;
McKay, NS;
Paulick, AM;
... Benzinger, TLS; + view all
(2020)
Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease.
NeuroImage: Clinical
, 28
, Article 102491. 10.1016/j.nicl.2020.102491.
|
|
|
Duarte, GS;
Rodrigues, FB;
Castelão, M;
Marques, RE;
Ferreira, J;
Sampaio, C;
Moore, AP;
(2020)
Botulinum toxin type A therapy for hemifacial spasm.
Cochrane Database of Systematic Reviews
, 11
, Article CD004899. 10.1002/14651858.CD004899.pub3.
|
|
Duarte, GS;
Rodrigues, FB;
Marques, RE;
Castelão, M;
Ferreira, J;
Sampaio, C;
Moore, AP;
(2020)
Botulinum toxin type A therapy for blepharospasm.
Cochrane Database of Systematic Reviews
, 11
, Article CD004900. 10.1002/14651858.CD004900.pub3.
|
|
Dumas, AA;
Pomella, N;
Rosser, G;
Guglielmi, L;
Vinel, C;
Millner, TO;
Rees, J;
... Marino, S; + view all
(2020)
Microglia promote glioblastoma via mTOR-mediated immunosuppression of the tumour microenvironment.
The EMBO Journal
, Article e103790. 10.15252/embj.2019103790.
|
|
|
Dunne, RA;
Aarsland, D;
O'Brien, JT;
Ballard, C;
Banerjee, S;
Fox, NC;
Isaacs, JD;
... Burns, A; + view all
(2020)
Mild cognitive impairment: the Manchester consensus.
Age and Ageing
10.1093/ageing/afaa228.
(In press).
|
|
|
Dutkiewicz, R;
Zetterberg, H;
Andreasson, U;
Blennow, K;
Nellgård, B;
(2020)
Dementia and CSF-Biomarkers for Alzheimer's Disease Predict Mortality after Acute Hip Fracture.
Acta Anaesthesiologica Scandinavica
, 64
(1)
pp. 93-103.
10.1111/aas.13472.
|
E
|
Eckerström, M;
Nilsson, S;
Zetterberg, H;
Blennow, K;
Grahn, A;
(2020)
Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study.
Scientific Reports
, 10
, Article 22400. 10.1038/s41598-020-79800-2.
|
|
|
Ehrenberg, AJ;
Khatun, A;
Coomans, E;
Betts, MJ;
Capraro, F;
Thijssen, EH;
Senkevich, K;
... Paterson, RW; + view all
(2020)
Relevance of biomarkers across different neurodegenerative.
Alzheimer's Research & Therapy
, 12
, Article 56. 10.1186/s13195-020-00601-w.
|
|
|
Engström, Å;
Jumisko, E;
Shahim, P;
Lehto, N;
Blennow, K;
Zetterberg, H;
Tegner, Y;
(2020)
Losing the identity of a hockey player: the long-term effects of concussions.
Concussion
, 5
(2)
, Article CNC74. 10.2217/cnc-2019-0014.
|
|
|
Eriksson, H;
Löwhagen Hendén, P;
Rentzos, A;
Pujol-Calderón, F;
Karlsson, JE;
Höglund, K;
Blennow, K;
... Zelano, J; + view all
(2020)
Acute symptomatic seizures and epilepsy after mechanical thrombectomy.
Epilepsy & Behavior
, 104
(B)
, Article 106520. 10.1016/j.yebeh.2019.106520.
|
|
Estevez Fraga, C;
Flower, M;
Tabrizi, S;
(2020)
Therapeutic strategies for Huntington’s disease.
Current Opinion in Neurology
, 33
(4)
pp. 508-518.
10.1097/WCO.0000000000000835.
|
|
Estevez-Fraga, C;
Magrinelli, F;
Latorre, A;
Houlden, H;
Tabrizi, SJ;
Bhatia, K;
(2020)
Movement disorders associated with expansions and intermediate repeats in the C9orf72 gene.
Presented at: MDS Virtual Congress 2020, Online conference.
|
|
|
Estevez-Fraga, C;
Magrinelli, F;
Latorre, A;
Cordivari, C;
Houlden, H;
Tinazzi, M;
Hemingway, C;
... Bhatia, KP; + view all
(2020)
A new family with GLRB-related hyperekplexia showing chorea in homo- and heterozygous variant carriers.
Parkinsonism and Related Disorders
, 79
pp. 97-99.
10.1016/j.parkreldis.2020.08.016.
|
|
Estevez-Fraga, C;
Scahill, R;
Rees, G;
Tabrizi, SJ;
Gregory, S;
(2020)
Diffusion imaging in Huntington's disease: comprehensive review.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2020-324377.
(In press).
|
|
F
|
Falgàs, N;
Ruiz-Peris, M;
Pérez-Millan, A;
Sala-Llonch, R;
Antonell, A;
Balasa, M;
Borrego-Écija, S;
... Sánchez-Valle, R; + view all
(2020)
Contribution of CSF biomarkers to early-onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures.
Human Brain Mapping
10.1002/hbm.24925.
(In press).
|
|
|
Fiford, C;
Nicholas, J;
Biessels, GJ;
Lane, C;
Cardoso, MJ;
Barnes, J;
(2020)
High blood pressure predicts hippocampal atrophy rate in cognitively impaired elders.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 12
(1)
, Article e12035. 10.1002/dad2.12035.
|
|
|
Fiford, C;
Sudre, C;
Pemberton, H;
Walsh, P;
Manning, E;
Malone, I;
Nicholas, J;
... Barnes, J; + view all
(2020)
Automated white matter hyperintensity segmentation using Bayesian Model Selection: assessment and correlations with cognitive change.
NeuroInformatics
10.1007/s12021-019-09439-6.
(In press).
|
|
|
Firth, NC;
Primativo, S;
Brotherhood, E;
Young, AL;
Yong, KXX;
Crutch, SJ;
Alexander, DC;
(2020)
Sequences of cognitive decline in typical Alzheimer's disease and posterior cortical atrophy estimated using a novel event‐based model of disease progression.
Alzheimer's & Dementia
, 16
(7)
pp. 965-973.
10.1002/alz.12083.
|
|
|
Flower, M;
Lomeikaite, V;
Holmans, P;
Jones, L;
Tabrizi, SJ;
Monckton, DG;
(2020)
Reply: The repeat variant in MSH3 is not a genetic modifier for spinocerebellar ataxia type 3 and Friedreich's ataxia.
Brain
, 143
(4)
e26.
10.1093/brain/awaa044.
|
|
Flower, MD;
Tabrizi, SJ;
(2020)
A small molecule kicks repeat expansion into reverse.
Nature Genetics
, 52
(2)
pp. 136-137.
10.1038/s41588-020-0577-6.
|
|
Foley, JA;
Dore, C;
Zarkali, A;
Livingston, G;
Cipolotti, L;
Mummery, CJ;
Weil, RS;
(2020)
Evaluation of START (STrAtegies for RelaTives) adapted for carers of people with Lewy body dementia.
Future Healthcare Journal
, 7
(3)
e27-e29.
10.7861/fhj.2020-0003.
|
|
Franzmeier, N;
Koutsouleris, N;
Benzinger, T;
Goate, A;
Karch, CM;
Fagan, AM;
McDade, E;
... Ewers, M; + view all
(2020)
Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease-informed machine-learning.
Alzheimer's and Dementia
, 16
(3)
pp. 501-511.
10.1002/alz.12032.
|
|
|
Franzmeier, N;
Suárez-Calvet, M;
Frontzkowski, L;
Moore, A;
Hohman, TJ;
Morenas-Rodriguez, E;
Nuscher, B;
... Alzheimer’s Disease Neuroimaging Initiative (ADNI); + view all
(2020)
Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration.
Molecular Neurodegeneration
, 15
(1)
, Article 57. 10.1186/s13024-020-00407-2.
|
|
|
Frisoni, GB;
Molinuevo, JL;
Altomare, D;
Carrera, E;
Barkhof, F;
Berkhof, J;
Delrieu, J;
... Ritchie, C; + view all
(2020)
Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies.
Alzheimer's & Dementia
, 16
(10)
pp. 1457-1468.
10.1002/alz.12132.
|
G
|
Gafson, AR;
Barthélemy, NR;
Bomont, P;
Carare, RO;
Durham, HD;
Julien, J-P;
Kuhle, J;
... Matthews, PM; + view all
(2020)
Neurofilaments: neurobiological foundations for biomarker applications.
Brain
, 143
(7)
pp. 1975-1998.
10.1093/brain/awaa098.
|
|
Gang, Q;
Bettencourt, C;
Holton, J;
Lovejoy, C;
Chelban, V;
Oconnor, E;
Yuan, Y;
... Houlden, H; + view all
(2020)
A novel frameshift deletion in autosomal recessive SBF1-related syndromic neuropathy with necklace fibres.
Journal of Neurology
10.1007/s00415-020-09827-y.
(In press).
|
|
|
Gao, Y;
Wang, T;
Yu, X;
International FTD-Genomics Consortium (IFGC);
Zhao, H;
Zeng, P;
(2020)
Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis.
Scientific Reports
, 10
, Article 12184. 10.1038/s41598-020-68848-9.
|
|
|
Gard, A;
Lehto, N;
Engström, Å;
Shahim, P;
Zetterberg, H;
Blennow, K;
Marklund, N;
(2020)
Quality of life of ice hockey players after retirement due to concussions.
Concussion
10.2217/cnc-2020-0007.
|
|
|
Garland, P;
Morton, MJ;
Haskins, W;
Zolnourian, A;
Durnford, A;
Gaastra, B;
Toombs, J;
... Galea, I; + view all
(2020)
Haemoglobin causes neuronal damage in vivo which is preventable by haptoglobin.
Brain Communications
, 2
(1)
, Article fcz053. 10.1093/braincomms/fcz053.
|
|
|
Ghosh, R;
Wood-Kaczmar, A;
Dobson, L;
Smith, EJ;
Sirinathsinghji, EC;
Kriston-Vizi, J;
Hargreaves, IP;
... Tabrizi, SJ; + view all
(2020)
Expression of mutant exon 1 huntingtin fragments in human neural stem cells and neurons causes inclusion formation and mitochondrial dysfunction.
FASEB Journal
10.1096/fj.201902277RR.
|
|
|
Gill, ON;
Spencer, Y;
Richard-Loendt, A;
Kelly, C;
Brown, D;
Sinka, K;
Andrews, N;
... Brandner, S; + view all
(2020)
Prevalence in Britain of abnormal prion protein in human appendices before and after exposure to the cattle BSE epizootic.
Acta Neuropathologica
10.1007/s00401-020-02153-7.
(In press).
|
|
|
Ging, Heather;
(2020)
Investigating the Role of Modifiers in Trinucleotide Repeat Diseases.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
|
Graham, NSN;
Jolly, A;
Zimmerman, K;
Bourke, NJ;
Scott, G;
Cole, JH;
Schott, JM;
(2020)
Diffuse axonal injury predicts neurodegeneration after moderate–severe traumatic brain injury.
Brain
, 143
(12)
pp. 3685-3698.
10.1093/brain/awaa316.
|
|
Graham, NSN;
Zimmerman, KA;
Bertolini, G;
Magnoni, S;
Oddo, M;
Zetterberg, H;
Moro, F;
... Sharp, DJ; + view all
(2020)
Multicentre longitudinal study of fluid and neuroimaging BIOmarkers of AXonal injury after traumatic brain injury: the BIO-AX-TBI study protocol.
BMJ Open
, 10
(11)
, Article e042093. 10.1136/bmjopen-2020-042093.
|
|
|
Gratwicke, J;
Zrinzo, L;
Kahan, J;
Peters, A;
Brechany, U;
McNichol, A;
Beigi, M;
... Foltynie, T; + view all
(2020)
Bilateral Nucleus Basalis of Meynert Deep Brain Stimulation for dementia with Lewy bodies A Randomised Clinical Trial.
Brain Stimulation
10.1016/j.brs.2020.04.010.
(In press).
|
|
|
Gray, E;
Oeckl, P;
Amador, MDM;
Andreasson, U;
An, J;
Blennow, K;
Bowser, R;
... Otto, M; + view all
(2020)
A multi-center study of neurofilament assay reliability and inter-laboratory variability.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
, 21
(5-6)
pp. 452-458.
10.1080/21678421.2020.1779300.
|
|
Gregory, S;
Johnson, E;
Byrne, L;
Rodrigues, F;
Henderson, A;
Moss, J;
Thomas, D;
... Wild, E; + view all
(2020)
Characterising white matter in Huntington's disease.
Movement Disorders Clinical Practice
, 7
(1)
pp. 52-60.
10.1002/mdc3.12866.
|
|
|
Gregory, S;
Lohse, KR;
Johnson, EB;
Leavitt, BR;
Durr, A;
Roos, RAC;
Rees, G;
... Orth, M; + view all
(2020)
Longitudinal Structural MRI in Neurologically Healthy Adults.
Journal of Magnetic Resonance Imaging
10.1002/jmri.27203.
(In press).
|
|
|
Guarascio, R;
Salih, D;
Yasvoina, M;
Edwards, FA;
Cheetham, ME;
van der Spuy, J;
(2020)
Negative Regulator of Ubiquitin-Like Protein 1 modulates the autophagy-lysosomal pathway via p62 to facilitate the extracellular release of tau following proteasome impairment.
Human Molecular Genetics
, 29
(1)
pp. 80-96.
10.1093/hmg/ddz255.
|
|
Guelfi, S;
D'Sa, K;
Botía, JA;
Vandrovcova, J;
Reynolds, RH;
Zhang, D;
Trabzuni, D;
... Ryten, M; + view all
(2020)
Regulatory sites for splicing in human basal ganglia are enriched for disease-relevant information.
Nature Communications
, 11
, Article 1041. 10.1038/s41467-020-14483-x.
|
|
H
|
Hagberg, L;
Price, RW;
Zetterberg, H;
Fuchs, D;
Gisslén, M;
(2020)
Herpes zoster in HIV-1 infection: The role of CSF pleocytosis in secondary CSF escape and discordance.
PLOS One
, 15
(7)
, Article e0236162. 10.1371/journal.pone.0236162.
|
|
|
Halaas, NB;
Henjum, K;
Blennow, K;
Dakhil, S;
Idland, A-V;
Nilsson, LN;
Sederevicius, D;
... Fjell, AM; + view all
(2020)
CSF sTREM2 and Tau Work Together in Predicting Increased Temporal Lobe Atrophy in Older Adults.
Cerebral Cortex
, 30
(4)
pp. 2295-2306.
10.1093/cercor/bhz240.
|
|
Hallam, B;
Chan, J;
Gonzalez Costafreda, S;
Bhome, R;
Huntley, J;
(2020)
What are the neural correlates of meta-cognition and anosognosia in Alzheimer's disease? A systematic review.
Neurobiology of Aging
, 94
pp. 250-264.
10.1016/j.neurobiolaging.2020.06.011.
|
|
|
Hampel, H;
Lista, S;
Vanmechelen, E;
Zetterberg, H;
Giorgi, FS;
Galgani, A;
Blennow, K;
... Alzheimer’s Precision Medicine Initiative (APMI); + view all
(2020)
β-Secretase1 biological markers for Alzheimer's disease: state-of-art of validation and qualification.
Alzheimer's Research & Therapy
, 12
, Article 130. 10.1186/s13195-020-00686-3.
|
|
|
Hampel, H;
Vassar, R;
De Strooper, B;
Hardy, J;
Willem, M;
Singh, N;
Zhou, J;
... Vergallo, A; + view all
(2020)
The β-Secretase BACE1 in Alzheimer's Disease.
Biological Psychiatry
10.1016/j.biopsych.2020.02.001.
(In press).
|
|
|
Hanes, J;
Kovac, A;
Kvartsberg, H;
Kontsekova, E;
Fialova, L;
Katina, S;
Kovacech, B;
... Zilka, N; + view all
(2020)
Evaluation of a novel immunoassay to detect p-Tau Thr127 in the CSF to distinguish Alzheimer disease from other dementias.
Neurology
10.1212/WNL.0000000000010814.
(In press).
|
|
|
Hansen, D;
Ling, H;
Lashley, T;
Foley, JA;
Strand, C;
Eid, TM;
Holton, JL;
(2020)
Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson's disease dementia.
Neuropathology and Applied Neurobiology
, 47
(1)
pp. 143-156.
10.1111/nan.12648.
|
|
|
Hansson, O;
Cullen, N;
Zetterberg, H;
Blennow, K;
Mattsson-Carlgren, N;
(2020)
Plasma phosphorylated tau181 and neurodegeneration in Alzheimer's disease.
Annals of Clinical and Translational Neurology
10.1002/acn3.51253.
(In press).
|
|
|
Hansson, O;
Rutz, S;
Zetterberg, H;
Bauer, E;
Hähl, T;
Manuilova, E;
Mert, MC;
... Stomrud, E; + view all
(2020)
Pre-analytical protocol for measuring Alzheimer's disease biomarkers in fresh CSF.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 12
(1)
, Article e12137. 10.1002/dad2.12137.
|
|
|
Harding, Emma;
(2020)
'I'm still that person in there but I can't make it work': capturing the day-to-day impacts of a diagnosis of posterior cortical atrophy.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Hardy, CJD;
Yong, KXX;
Goll, JC;
Crutch, SJ;
Warren, JD;
(2020)
Impairments of auditory scene analysis in posterior cortical atrophy.
Brain
, Article awaa221. 10.1093/brain/awaa221.
(In press).
|
|
|
Haugg, A;
Sladky, R;
Skouras, S;
McDonald, A;
Craddock, C;
Kirschner, M;
Herdener, M;
... Scharnowski, F; + view all
(2020)
Can we predict real-time fMRI neurofeedback learning success from pretraining brain activity?
Human Brain Mapping
, 41
(14)
pp. 3839-3854.
10.1002/hbm.25089.
|
|
|
Hegde, RN;
Chiki, A;
Petricca, L;
Martufi, P;
Arbez, N;
Mouchiroud, L;
Auwerx, J;
... Lashuel, HA; + view all
(2020)
TBK1 phosphorylates mutant Huntingtin and suppresses its aggregation and toxicity in Huntington's disease models.
The EMBO Journal
, Article e104671. 10.15252/embj.2020104671.
(In press).
|
|
|
Heller, C;
Chan, E;
Foiani, MS;
Todd, E;
Russell, LL;
Greaves, CV;
Heslegrave, AJ;
... Rohrer, JD; + view all
(2020)
Plasma glial fibrillary acidic protein and neurofilament light chain are measures of disease severity in semantic variant primary progressive aphasia.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2020-325085.
(In press).
|
|
Heller, C;
Foiani, MS;
Moore, K;
Convery, R;
Bocchetta, M;
Neason, M;
Cash, DM;
... GENFI; + view all
(2020)
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2019-321954.
(In press).
|
|
|
Hensman Moss, Davina J;
(2020)
Identification of genetic factors underpinning phenotypic heterogeneity in Huntington's disease and other neurodegenerative disorders.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
|
Hithersay, R;
Baksh, RA;
Startin, CM;
Wijeratne, P;
Hamburg, S;
Carter, B;
LonDownS Consortium;
(2020)
Optimal age and outcome measures for Alzheimer's disease prevention trials in people with Down syndrome.
Alzheimer's & Dementia
10.1002/alz.12222.
(In press).
|
|
|
Hong, S;
Prokopenko, D;
Dobricic, V;
Kilpert, F;
Bos, I;
Vos, SJB;
Tijms, BM;
... Bertram, L; + view all
(2020)
Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset.
Translational Psychiatry
, 10
, Article 403. 10.1038/s41398-020-01074-z.
|
|
|
Hossain, I;
Mohammadian, M;
Takala, RSK;
Tenovuo, O;
Azurmendi Gil, L;
Frantzén, J;
van Gils, M;
... Posti, JP; + view all
(2020)
Admission Levels of Total Tau and β-Amyloid Isoforms 1–40 and 1–42 in Predicting the Outcome of Mild Traumatic Brain Injury.
Frontiers in Neurology
, 11
, Article 325. 10.3389/fneur.2020.00325.
|
|
|
Huebschmann, NA;
Luoto, TM;
Karr, JE;
Berghem, K;
Blennow, K;
Zetterberg, H;
Ashton, NJ;
... Iverson, GL; + view all
(2020)
Comparing Glial Fibrillary Acidic Protein (GFAP) in Serum and Plasma Following Mild Traumatic Brain Injury in Older Adults.
Frontiers in Neurology
, 11
, Article 1054. 10.3389/fneur.2020.01054.
|
|
|
Humphrey, J;
Birsa, N;
Milioto, C;
McLaughlin, M;
Ule, AM;
Robaldo, D;
Eberle, AB;
... Fratta, P; + view all
(2020)
FUS ALS-causative mutations impair FUS autoregulation and splicing factor networks through intron retention.
Nucleic Acids Research
10.1093/nar/gkaa410.
(In press).
|
|
|
Hyare, H;
De Vita, E;
Porter, M-C;
Simpson, I;
Ridgway, G;
Lowe, J;
Thompson, A;
... Thornton, JS; + view all
(2020)
Putaminal diffusion tensor imaging measures predict disease severity across human prion diseases.
Brain Communications
, 2
(1)
, Article fcaa032. 10.1093/braincomms/fcaa032.
|
|
I
|
Idland, AV;
Sala-Llonch, R;
Watne, LO;
Brækhus, A;
Hansson, O;
Blennow, K;
Zetterberg, H;
... Fjell, AM; + view all
(2020)
Biomarker profiling beyond amyloid and tau: cerebrospinal fluid markers, hippocampal atrophy, and memory change in cognitively unimpaired older adults.
Neurobiology of Aging
, 93
pp. 1-15.
10.1016/j.neurobiolaging.2020.04.002.
|
|
|
Iriondo, A;
García-Sebastian, M;
Arrospide, A;
Arriba, M;
Aurtenetxe, S;
Barandiaran, M;
Clerigue, M;
... Martínez-Lage, P; + view all
(2020)
Cerebrospinal Fluid 7-Ketocholesterol Level is Associated with Amyloid-β42 and White Matter Microstructure in Cognitively Healthy Adults.
Journal of Alzheimer's Disease
10.3233/JAD-200105.
(In press).
|
|
Ishihara, L;
Oliveri, D;
Wild, EJ;
(2020)
Neuropsychiatric comorbidities in Huntington's and Parkinson's Disease: A United States claims database analysis.
Annals of Clinical and Translational Neurology
10.1002/acn3.51252.
(In press).
|
|
|
Iverson, GL;
Posti, JP;
Öhman, J;
Blennow, K;
Zetterberg, H;
Luoto, TM;
(2020)
Reliability of serum S100B measurement following mild traumatic brain injury: a comparison of assay measurements from two laboratories.
Brain Injury
, 34
(9)
pp. 1237-1244.
10.1080/02699052.2020.1800092.
|
J
|
Janelidze, S;
Mattsson, N;
Palmqvist, S;
Smith, R;
Beach, TG;
Serrano, GE;
Chai, X;
... Hansson, O; + view all
(2020)
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia.
Nature Medicine
, 26
pp. 379-386.
10.1038/s41591-020-0755-1.
|
|
Jaunmuktane, Z;
Brandner, S;
(2020)
The role of prion-like mechanisms in neurodegenerative diseases.
Neuropathology and Applied Neurobiology
10.1111/nan.12592.
(In press).
|
|
Jaunmuktane, Z;
Mahadeva, U;
Green, A;
Sekhawat, V;
Barrett, NA;
Childs, L;
Shankar-Hari, M;
... Brandner, S; + view all
(2020)
Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID-19.
Acta Neuropathologica
10.1007/s00401-020-02190-2.
(In press).
|
|
|
Jimenez, DA;
Bond, RL;
Requena-Komuro, M-C;
Sivasathiaseelan, H;
Marshall, CR;
Russell, LL;
Greaves, C;
... Warren, JD; + view all
(2020)
Altered phobic reactions in frontotemporal dementia: a behavioural and neuroanatomical analysis.
Cortex
10.1016/j.cortex.2020.05.016.
(In press).
|
|
|
Johnson, EB;
Ziegler, G;
Penny, W;
Rees, G;
Tabrizi, SJ;
Scahill, RI;
Gregory, S;
(2020)
Dynamics of Cortical Degeneration Over a Decade in Huntington's Disease.
Biological Psychiatry
10.1016/j.biopsych.2020.11.009.
(In press).
|
|
|
Johnson, JCS;
Jiang, J;
Bond, RL;
Benhamou, E;
Requena-Komuro, M-C;
Russell, LL;
Greaves, C;
... Hardy, CJD; + view all
(2020)
Impaired phonemic discrimination in logopenic variant primary progressive aphasia.
Annals of Clinical and Translational Neurology
, 7
(7)
pp. 1252-1257.
10.1002/acn3.51101.
|
|
|
Johnson, JCS;
Marshall, CR;
Weil, RS;
Bamiou, D-E;
Hardy, CJD;
Warren, JD;
(2020)
Hearing and dementia: from ears to brain.
Brain
10.1093/brain/awaa429.
(In press).
|
|
|
Jones, E;
Hummerich, H;
Viré, E;
Uphill, J;
Dimitriadis, A;
Speedy, H;
Campbell, T;
... Mead, S; + view all
(2020)
Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study.
The Lancet Neurology
, 19
(10)
pp. 840-848.
10.1016/S1474-4422(20)30273-8.
|
|
Jons, D;
Zetterberg, H;
Malmeström, C;
Bergström, T;
Axelsson, M;
Blennow, K;
Thulin, M;
... Andersen, O; + view all
(2020)
Intrathecal immunoreactivity in people with or without previous infectious mononucleosis.
Acta Neurologica Scandinavica
, 142
(2)
pp. 161-168.
10.1111/ane.13280.
|
K
|
Kacprzak, T;
Herbel, J;
Nicola, A;
Sgier, R;
Tarsitano, F;
Bruderer, C;
Amara, A;
... Weller, J; + view all
(2020)
Monte Carlo control loops for cosmic shear cosmology with DES Year 1 data.
Physical Review D
, 101
(8)
, Article 082003. 10.1103/PhysRevD.101.082003.
|
|
|
Kalafateli, AL;
Satir, TM;
Vallöf, D;
Zetterberg, H;
Jerlhag, E;
(2020)
An amylin and calcitonin receptor agonist modulates alcohol behaviors by acting on reward-related areas in the brain.
Progress in Neurobiology
, Article 101969. 10.1016/j.pneurobio.2020.101969.
(In press).
|
|
|
Kamalidehghan, B;
Habibi, M;
Afjeh, SS;
Shoai, M;
Alidoost, S;
Ghale, RA;
Eshghifar, N;
(2020)
The importance of small non-coding RNAs in human reproduction: A review article.
Application of Clinical Genetics
, 13
pp. 1-11.
10.2147/TACG.S207491.
|
|
|
Kanberg, N;
Ashton, NJ;
Andersson, L-M;
Yilmaz, A;
Lindh, M;
Nilsson, S;
Price, RW;
... Gisslén, M; + view all
(2020)
Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19.
Neurology
, 95
(12)
e1754-e1759.
10.1212/WNL.0000000000010111.
|
|
Kang, MS;
Aliaga, AA;
Shin, M;
Mathotaarachchi, S;
Benedet, AL;
Pascoal, TA;
Therriault, J;
... Rosa-Neto, P; + view all
(2020)
Amyloid-beta modulates the association between neurofilament light chain and brain atrophy in Alzheimer’s disease.
Molecular Psychiatry
10.1038/s41380-020-0818-1.
(In press).
|
|
|
Karikari, TK;
Keeling, S;
Hill, E;
Lantero Rodriguez, J;
Nagel, DA;
Becker, B;
Höglund, K;
... Moffat, KG; + view all
(2020)
An extensive plasmid library to prepare tau protein variants and study their functional biochemistry.
ACS Chemical Neuroscience
, 11
(19)
pp. 3117-3129.
10.1021/acschemneuro.0c00469.
|
|
|
Karikari, TK;
Pascoal, TA;
Ashton, NJ;
Janelidze, S;
Benedet, AL;
Rodriguez, JL;
Chamoun, M;
... Blennow, K; + view all
(2020)
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
The Lancet Neurology
, 19
(5)
pp. 422-433.
10.1016/S1474-4422(20)30071-5.
|
|
Keddie, S;
Ziff, O;
Chou, MKL;
Taylor, RL;
Heslegrave, A;
Garr, E;
Lakdawala, N;
... Lunn, MP; + view all
(2020)
Laboratory biomarkers associated with COVID-19 severity and management.
Clinical Immunology
, 221
, Article 108614. 10.1016/j.clim.2020.108614.
|
|
Keddie, S;
Foldes, D;
Caimari, F;
Baldeweg, SE;
Bomsztyk, J;
Ziff, OJ;
Fehmi, J;
... Lunn, MP; + view all
(2020)
Clinical characteristics, risk factors, and outcomes of POEMS syndrome: A longitudinal cohort study.
Neurology
, 95
(3)
e268-e279.
10.1212/WNL.0000000000009940.
|
|
Keddie, S;
Nagendran, A;
Cox, T;
Bomsztyk, J;
Jaunmuktane, Z;
Brandner, S;
Manji, H;
... Lunn, MP; + view all
(2020)
Peripheral nerve neurolymphomatosis: clinical features, treatment and outcomes.
Muscle & Nerve
, 62
(5)
pp. 617-625.
10.1002/mus.27045.
|
|
Keshavan, A;
Wellington, H;
Chen, Z;
Khatun, A;
Chapman, M;
Hart, M;
Cash, D;
... Schott, JM; + view all
(2020)
Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 12
(1)
, Article e12097. 10.1002/dad2.12097.
|
|
|
Khatun, A;
Paterson, RW;
Schöll, M;
(2020)
University College London/University of Gothenburg PhD course "Biomarkers in neurodegenerative diseases" 2019—course organisation.
Alzheimer's Research & Therapy
, 12
, Article 18. 10.1186/s13195-020-0583-z.
|
|
|
Khoo, A;
McLoughlin, B;
Cheema, S;
Weil, RS;
Lambert, C;
Manji, H;
Zandi, MS;
(2020)
Postinfectious brainstem encephalitis associated with SARS-CoV-2.
Journal of Neurology, Neurosurgery & Psychiatry
, 91
(9)
pp. 1013-1014.
10.1136/jnnp-2020-323816.
|
|
Knopman, DS;
Lundt, ES;
Therneau, TM;
Albertson, SM;
Gunter, JL;
Senjem, ML;
Schwarz, CG;
... Alzheimer’s Disease Neuroimaging Initiative; + view all
(2020)
Association of Initial β-Amyloid Levels With Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive Impairment.
JAMA Neurology
10.1001/jamaneurol.2020.3921.
(In press).
|
|
Konijnenberg, E;
Tijms, BM;
Gobom, J;
Dobricic, V;
Bos, I;
Vos, S;
Tsolaki, M;
... Visser, PJ; + view all
(2020)
APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease.
Alzheimer's Research & Therapy
, 12
, Article 65. 10.1186/s13195-020-00628-z.
|
|
|
Kopach, O;
Esteras, N;
Wray, S;
Rusakov, DA;
Abramov, AY;
(2020)
Maturation and phenotype of pathophysiological neuronal excitability of human cells in tau-related dementia.
Journal of Cell Science
, 133
(10)
, Article jcs241687. 10.1242/jcs.241687.
|
|
Korecka, M;
Figurski, MJ;
Landau, SM;
Brylska, M;
Alexander, J;
Blennow, K;
Zetterberg, H;
... Alzheimer’s Disease Neuroimaging Initiative; + view all
(2020)
Analytical and Clinical Performance of Amyloid-Beta Peptides Measurements in CSF of ADNIGO/2 Participants by an LC–MS/MS Reference Method.
Clinical Chemistry
, 66
(4)
pp. 587-597.
10.1093/clinchem/hvaa012.
|
|
Kranaster, L;
Hoyer, C;
Mindt, S;
Neumaier, M;
Mueller, N;
Zill, P;
Schwarz, MJ;
... Sartorius, A; + view all
(2020)
The novel seizure quality index for the antidepressant outcome prediction in electroconvulsive therapy: association with biomarkers in the cerebrospinal fluid.
European Archives of Psychiatry and Clinical Neuroscience
, 270
pp. 911-919.
10.1007/s00406-019-01086-x.
|
|
Kresge, HA;
Liu, D;
Gupta, DK;
Moore, EE;
Osborn, KE;
Acosta, LMY;
Bell, SP;
... Jefferson, AL; + view all
(2020)
Lower Left Ventricular Ejection Fraction Relates to Cerebrospinal Fluid Biomarker Evidence of Neurodegeneration in Older Adults.
Journal of Alzheimer's Disease
10.3233/JAD-190813.
(In press).
|
|
Kumar, VV;
Huang, H;
Zhao, L;
Verble, DD;
Nutaitis, A;
Tharwani, SD;
Brown, AL;
... Wharton, W; + view all
(2020)
Baseline Results: The Association between Cardiovascular Risk and Preclinical Alzheimer’s Disease Pathology (ASCEND) Study.
Journal of Alzheimer's Disease
, 75
(1)
pp. 109-117.
10.3233/JAD-191103.
|
L
|
La Joie, Renaud;
Olsen, Rosanna;
Berron, David;
Amunts, Katrin;
Augustinack, Jean;
Bakker, Arnold;
Bender, Andrew;
... Daugherty, Ana M; + view all
(2020)
The development of a valid, reliable, harmonized segmentation protocol for hippocampal subfields and medial temporal lobe cortices: A progress update.
Presented at: UNSPECIFIED.
|
|
Landles, C;
Milton, RE;
Ali, N;
Flomen, R;
Flower, M;
Schindler, F;
Gomez-Paredes, C;
... Bates, GP; + view all
(2020)
Subcellular Localization And Formation Of Huntingtin Aggregates Correlates With Symptom Onset And Progression In A Huntington’S Disease Model.
Brain Communications
, 2
(2)
, Article fcaa066. 10.1093/braincomms/fcaa066.
|
|
|
Langley, C;
Gregory, S;
Osborne-Crowley, K;
O'Callaghan, C;
Zeun, P;
Lowe, J;
Johnson, EB;
... Sahakian, BJ; + view all
(2020)
Fronto-striatal circuits for cognitive flexibility in far from onset Huntington's disease: evidence from the Young Adult Study.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2020-324104.
(In press).
|
|
|
Lantero Rodriguez, J;
Karikari, TK;
Suárez-Calvet, M;
Troakes, C;
King, A;
Emersic, A;
Aarsland, D;
... Ashton, NJ; + view all
(2020)
Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline.
Acta Neuropathologic
10.1007/s00401-020-02195-x.
(In press).
|
|
|
Lauwers, E;
Lalli, G;
Brandner, S;
Collinge, J;
Compernolle, V;
Duyckaerts, C;
Edgren, G;
... De Strooper, B; + view all
(2020)
Potential human transmission of amyloid β pathology: surveillance and risks.
The Lancet Neurology
, 19
(10)
pp. 872-878.
10.1016/S1474-4422(20)30238-6.
|
|
Laverse, E;
Guo, T;
Zimmerman, K;
Foiani, MS;
Velani, B;
Morrow, P;
Adejuwon, A;
... Morris, HR; + view all
(2020)
Plasma glial fibrillary acidic protein and neurofilament light chain, but not tau, are biomarkers of sports-related mild traumatic brain injury.
Brain Communications
, 2
(2)
, Article fcaa137. 10.1093/braincomms/fcaa137.
|
|
|
Le Blanc, G;
Jetté Pomerleau, V;
McCarthy, J;
Borroni, B;
Van Swieten, J;
Galimberti, D;
Sanchez-Valle, R;
... GENetic Frontotemporal dementia Initiative (GENFI); + view all
(2020)
Faster Cortical Thinning and Surface Area Loss in Presymptomatic and Symptomatic C9orf72 Repeat Expansion Adult Carriers.
Annals of Neurology
, 88
(1)
pp. 113-122.
10.1002/ana.25748.
|
|
Leavitt, BR;
Tabrizi, SJ;
(2020)
Antisense oligonucleotides for neurodegeneration.
Science
, 367
(6485)
pp. 1428-1429.
10.1126/science.aba4624.
|
|
|
Lewis, PA;
Plun-Favreau, H;
Rowley, M;
Spillane, J;
(2020)
Pierre D. and the first photographs of Parkinson's disease.
Movement Disorders
10.1002/mds.27965.
(In press).
|
|
|
Lindström, J;
Bremell, D;
Grahn, A;
Blennow, K;
Zetterberg, H;
Studahl, M;
(2020)
CXCL13 in patients with facial palsy caused by varicella zoster virus and Borrelia burgdorferi: a comparative study.
Diagnostic Microbiology and Infectious Disease
, 98
(1)
10.1016/j.diagmicrobio.2020.115095.
(In press).
|
|
|
Lines, G;
Casey, JM;
Preza, E;
Wray, S;
(2020)
Modelling frontotemporal dementia using patient-derived induced pluripotent stem cells.
Molecular and Cellular Neuroscience
, 109
, Article 103553. 10.1016/j.mcn.2020.103553.
|
|
Ling, H;
Gelpi, E;
Davey, K;
Jaunmuktane, Z;
Mok, KY;
Jabbari, E;
Simone, R;
... Revesz, T; + view all
(2020)
Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates.
Acta Neuropathologica
10.1007/s00401-019-02119-4.
(In press).
|
|
|
Litchfield, K;
Stanislaw, S;
Spain, L;
Gallegos, LL;
Rowan, A;
Schnidrig, D;
Rosenbaum, H;
... Turajlic, S; + view all
(2020)
Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue.
Cell Reports
, 31
(5)
p. 107550.
10.1016/j.celrep.2020.107550.
|
|
Liu, W;
Taso, O;
Wang, R;
Bayram, S;
Graham, AC;
Garcia-Reitboeck, P;
Mallach, A;
... Salih, DA; + view all
(2020)
Trem2 promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions.
Human Molecular Genetics
10.1093/hmg/ddaa209.
(In press).
|
|
|
Livingston, G;
Huntley, J;
Sommerlad, A;
Ames, D;
Ballard, C;
Banerjee, S;
Brayne, C;
... Mukadam, N; + view all
(2020)
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.
The Lancet
, 396
(10248)
pp. 413-446.
10.1016/s0140-6736(20)30367-6.
|
|
Llorens, F;
Hermann, P;
Villar-Piqué, A;
Diaz-Lucena, D;
Nägga, K;
Hansson, O;
Santana, I;
... Zerr, I; + view all
(2020)
Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia.
Nature Communications
, 11
, Article 619. 10.1038/s41467-020-14373-2.
|
|
|
Low, Y-H;
Asi, Y;
Foti, SC;
Lashley, T;
(2020)
Heterogeneous Nuclear Ribonucleoproteins: Implications in Neurological Diseases.
Molecular Neurobiology
10.1007/s12035-020-02137-4.
(In press).
|
|
|
Lowe, AJ;
Sjödin, S;
Rodrigues, FB;
Byrne, LM;
Blennow, K;
Tortelli, R;
Zetterberg, H;
(2020)
Cerebrospinal fluid endo-lysosomal proteins as potential biomarkers for Huntington's disease.
PLoS One
, 15
(8)
, Article e0233820. 10.1371/journal.pone.0233820.
|
|
|
Lu, Kirsty;
Pavisic, Ivanna;
James, Sarah-Naomi;
Street, Rebecca;
Keuss, Sarah E;
Buchanan, Sarah M;
Wagen, Aaron;
... Schott, Jonathan M; + view all
(2020)
Accelerated Forgetting is sensitive to β-amyloid pathology and cerebral atrophy in cognitively-normal 72-year-olds.
Presented at: Alzheimer's Association International Conference (AAIC) 2020, Online conference.
|
|
|
Lu, K;
Nicholas, JM;
James, S;
Lane, CA;
Parker, TD;
Keshavan, A;
Keuss, SE;
... Crutch, SJ; + view all
(2020)
Increased variability in reaction time is associated with amyloid beta pathology at age 70.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 12
(1)
, Article e12076. 10.1002/dad2.12076.
|
|
M
|
Malpetti, Maura;
Kievit, Rogier A;
Jones, P Simon;
Rittman, Timothy;
Tsvetanov, Kamen A;
van Swieten, John C;
Borroni, Barbara;
... Rowe, James B; + view all
(2020)
Trajectory of apathy, cognition and neural correlates in the decades before symptoms in frontotemporal dementia.
Presented at: UNSPECIFIED.
|
|
Manniche, C;
Simonsen, AH;
Hasselbalch, SG;
Andreasson, U;
Zetterberg, H;
Blennow, K;
Høgh, P;
... Hejl, A-M; + view all
(2020)
Cerebrospinal Fluid Biomarkers to Differentiate Idiopathic Normal Pressure Hydrocephalus from Subcortical Ischemic Vascular Disease.
Journal of Alzheimer's Disease
10.3233/JAD-200036.
(In press).
|
|
|
Mansur, A;
Rabiner, EA;
Comley, RA;
Lewis, Y;
Middleton, LT;
Huiban, M;
Passchier, J;
... Rowe, J; + view all
(2020)
Characterization of 3 PET Tracers for Quantification of Mitochondrial and Synaptic Function in Healthy Human Brain: {18}^F-BCPP-EF, {11}^C-SA-4503, and {11}^C-UCB-J.
The Journal of Nuclear Medicine
, 61
(1)
pp. 96-103.
10.2967/jnumed.119.228080.
|
|
|
Marinescu, RV;
Oxtoby, NP;
Young, AL;
Bron, EE;
Toga, AW;
Weiner, MW;
Barkhof, F;
... Alexander, DC; + view all
(2020)
The Alzheimer's Disease Prediction Of Longitudinal Evolution (TADPOLE) Challenge: Results after 1 Year Follow-up.
ArXiv
|
|
Markey, K;
Mitchell, J;
Botfield, H;
Ottridge, RS;
Matthews, T;
Krishnan, A;
Woolley, R;
... Sinclair, AJ; + view all
(2020)
11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial.
Brain Communications
, 2
(1)
, Article fcz050. 10.1093/braincomms/fcz050.
|
|
|
Marshall, CR;
Warren, JD;
(2020)
Reply: Brain-behaviour associations and neural representations of emotions in frontotemporal dementia.
Brain
, 143
(3)
e18.
10.1093/brain/awaa006.
|
|
Mason, MA;
Gomez-Paredes, C;
Sathasivam, K;
Neueder, A;
Papadopoulou, A-S;
Bates, GP;
(2020)
Silencing Srsf6 does not modulate incomplete splicing of the huntingtin gene in Huntington's disease models.
Scientific Reports
, 10
, Article 14057. 10.1038/s41598-020-71111-w.
|
|
|
Mason, SA;
Al Saikhan, L;
Jones, S;
Bale, G;
James, S-N;
Murray-Smith, H;
Rapala, A;
... Hughes, AD; + view all
(2020)
Study Protocol – Insight 46 Cardiovascular: A Sub-study of
the MRC National Survey of Health and Development.
Artery Research
, 26
(3)
pp. 170-179.
10.2991/artres.k.200417.001.
|
|
|
Mattsson-Carlgren, N;
Andersson, E;
Janelidze, S;
Ossenkoppele, R;
Insel, P;
Strandberg, O;
Zetterberg, H;
... Hansson, O; + view all
(2020)
Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease.
Science Advances
, 6
(16)
, Article eaaz2387. 10.1126/sciadv.aaz2387.
|
|
|
Maynard, J;
Okuchi, S;
Wastling, S;
Busaidi, AA;
Almossawi, O;
Mbatha, W;
Brandner, S;
... Thust, S; + view all
(2020)
World Health Organization Grade II/III Glioma Molecular Status: Prediction by MRI Morphologic Features and Apparent Diffusion Coefficient.
Radiology
, 296
(1)
pp. 111-121.
10.1148/radiol.2020191832.
|
|
McColgan, P;
Joubert, J;
Tabrizi, SJ;
Rees, G;
(2020)
The human motor cortex microcircuit: insights for neurodegenerative disease.
Nature Reviews Neuroscience
, 21
pp. 401-415.
10.1038/s41583-020-0315-1.
|
|
Mencacci, NE;
Reynolds, R;
Ruiz, SG;
Vandrovcova, J;
Forabosco, P;
Sánchez-Ferrer, A;
Volpato, V;
... Ryten, M; + view all
(2020)
Dystonia genes functionally converge in specific neurons and share neurobiology with psychiatric disorders.
Brain
, Article awaa217. 10.1093/brain/awaa217.
(In press).
|
|
|
Mengoudi, K;
Ravi, D;
Yong, K;
Primativo, S;
Pavisic, I;
Brotherhood, E;
Lu, K;
... Alexander, D; + view all
(2020)
Augmenting Dementia Cognitive Assessment with Instruction-less Eye-tracking Tests.
IEEE Journal of Biomedical and Health Informatics
10.1109/JBHI.2020.3004686.
(In press).
|
|
|
Meregalli, C;
Fumagalli, G;
Alberti, P;
Canta, A;
Chiorazzi, A;
Monza, L;
Pozzi, E;
... Marmiroli, P; + view all
(2020)
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity.
Archives of Toxicology
, 94
pp. 2517-2522.
10.1007/s00204-020-02755-w.
|
|
Michno, W;
Wehrli, P;
Meier, S;
Sehlin, D;
Syvänen, S;
Zetterberg, H;
Blennow, K;
(2020)
Chemical Imaging of Evolving Amyloid Plaque Pathology and Associated Aβ Peptide Aggregation in a Transgenic Mouse Model of Alzheimer's Disease.
Journal of Neurochemistry
, 152
(5)
pp. 602-616.
10.1111/jnc.14888.
|
|
Miki, Y;
Foti, SC;
Hansen, D;
Strand, KM;
Asi, YT;
Tsushima, E;
Jaunmuktane, Z;
... Holton, JL; + view all
(2020)
Hippocampal α-synuclein pathology correlates with memory impairment in multiple system atrophy.
Brain
, 143
(6)
pp. 1798-1810.
10.1093/brain/awaa126.
|
|
Miki, Y;
Ling, H;
Crampsie, S;
Mummery, CJ;
Rohrer, JD;
Jaunmuktane, Z;
Lashley, T;
(2020)
Corticospinal tract degeneration and temporal lobe atrophy in frontotemporal lobar degeneration TDP-43 type C pathology.
Neuropathology and Applied Neurobiology
, 46
(3)
pp. 296-299.
10.1111/nan.12582.
|
|
Milà-Alomà, M;
Salvadó, G;
Gispert, JD;
Vilor-Tejedor, N;
Grau-Rivera, O;
Sala-Vila, A;
Sánchez-Benavides, G;
... ALFA study; + view all
(2020)
Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum.
Alzheimer's & Dementia
10.1002/alz.12131.
(In press).
|
|
|
Mila-Aloma, M;
Salvado, G;
Shekari, M;
Grau-Rivera, O;
Sala-Vila, A;
Sanchez-Benavides, G;
Arenaza-Urquijo, EM;
... Molinuevo, JL; + view all
(2020)
Comparative Analysis of Different Definitions of Amyloid-beta Positivity to Detect Early Downstream Pathophysiological Alterations in Preclinical Alzheimer.
The Journal of Prevention of Alzheimer’s Disease
, 8
(1)
pp. 68-77.
10.14283/jpad.2020.51.
|
|
|
Minta, K;
Brinkmalm, G;
Al Nimer, F;
Thelin, EP;
Piehl, F;
Tullberg, M;
Jeppsson, A;
... Andreasson, U; + view all
(2020)
Dynamics of cerebrospinal fluid levels of matrix metalloproteinases in human traumatic brain injury.
Scientific Reports
, 10
, Article 18075. 10.1038/s41598-020-75233-z.
|
|
|
Minta, K;
Brinkmalm, G;
Janelidze, S;
Sjödin, S;
Portelius, E;
Stomrud, E;
Zetterberg, H;
... Andreasson, U; + view all
(2020)
Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases.
Alzheimer's Research & Therapy
, 12
(1)
, Article 19. 10.1186/s13195-020-00585-7.
|
|
|
Mitchell, CT;
Krier, I;
Arjomand, J;
Borowsky, B;
Tabrizi, SJ;
Leavitt, BR;
TRACK-HD Investigators;
(2020)
Longitudinal expression changes are weak correlates of disease progression in Huntington's disease.
Brain Communications
, 2
(2)
, Article fcaa172. 10.1093/braincomms/fcaa172.
|
|
|
Mollenhauer, B;
Dakna, M;
Kruse, N;
Galasko, D;
Foroud, T;
Zetterberg, H;
Schade, S;
... Graham, D; + view all
(2020)
Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression.
Movement Disorders
10.1002/mds.28206.
(In press).
|
|
|
Moore, EE;
Gifford, KA;
Khan, OA;
Liu, D;
Pechman, KR;
Acosta, LMY;
Bell, SP;
... Jefferson, AL; + view all
(2020)
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic dysfunction, and axonal injury relate to atrophy in structural brain regions specific to Alzheimer's disease.
Alzheimer’s & Dementia
, 16
(6)
pp. 883-895.
10.1002/alz.12087.
|
|
Moore, EE;
Liu, D;
Pechman, KR;
Acosta, LMY;
Bell, SP;
Davis, LT;
Blennow, K;
... Jefferson, AL; + view all
(2020)
Mild Cognitive Impairment Staging Yields Genetic Susceptibility, Biomarker, and Neuroimaging Differences.
Frontiers in Aging Neuroscience
, 12
, Article 139. 10.3389/fnagi.2020.00139.
|
|
|
Moore, K;
Convery, R;
Bocchetta, M;
Neason, M;
Cash, DM;
Greaves, C;
Russell, LL;
... Anderl-Straub, S; + view all
(2020)
A modified Camel and Cactus Test detects presymptomatic semantic impairment in genetic frontotemporal dementia within the GENFI cohort.
Applied Neuropsychology: Adult
10.1080/23279095.2020.1716357.
(In press).
|
|
Moscoso, A;
Grothe, M;
Ashton, N;
Karikari, T;
Rodriguez, JL;
Snellman, A;
Suárez-Calvet, M;
... Alzheimer’s Disease Neuroimaging Initiative; + view all
(2020)
Time course of phosphorylated tau181 in blood across the Alzheimer's disease spectrum.
MedRxiv: Cold Spring Harbor, NY, USA.
|
|
Mouton-Liger, F;
Dumurgier, J;
Cognat, E;
Hourregue, C;
Zetterberg, H;
Vanderstichele, H;
Vanmechelen, E;
... Paquet, C; + view all
(2020)
CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer’s disease.
Alzheimer's Research & Therapy
, 12
, Article 88. 10.1186/s13195-020-00655-w.
|
|
|
Mullin, S;
Smith, L;
Lee, K;
D'Souza, G;
Woodgate, P;
Elflein, J;
Hällqvist, J;
... Schapira, AHV; + view all
(2020)
Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations:
A Nonrandomized, Noncontrolled Trial.
JAMA Neurology
10.1001/jamaneurol.2019.4611.
|
|
|
Mushtaq, M;
Kovalevska, L;
Darekar, S;
Abramsson, A;
Zetterberg, H;
Kashuba, V;
Klein, G;
... Kashuba, E; + view all
(2020)
Cell stemness is maintained upon concurrent expression of RB and the mitochondrial ribosomal protein S18-2.
Proceedings of the National Academy of Sciences of the United States of America
10.1073/pnas.1922535117.
(In press).
|
|
N
|
Nair, RR;
Tibbit, C;
Thompson, D;
McLeod, R;
Nakhuda, A;
Simon, MM;
Baloh, RH;
... Cunningham, TJ; + view all
(2020)
Sizing, stabilising, and cloning repeat-expansions for gene targeting constructs.
Methods
10.1016/j.ymeth.2020.07.007.
(In press).
|
|
|
Natera-Villalba, E;
Ros-Castello, V;
Sanchez-Sanchez, A;
Gomez-Lopez, A;
Perez-Torre, P;
Fanjul-Arbos, S;
Garcia-Ribas, G;
... Alonso-Canovas, A; + view all
(2020)
PRO-PARK study: Is there an association between PROfessional occupation and Parkinson's disease?
Presented at: Movement-Disorder-Society (MDS) International Virtual Congress.
|
|
Nath, SR;
Lieberman, ML;
Yu, Z;
Marchioretti, C;
Jones, ST;
Danby, ECE;
Van Pelt, KM;
... Lieberman, AP; + view all
(2020)
MEF2 impairment underlies skeletal muscle atrophy in polyglutamine disease.
Acta Neuropathologica
, 140
pp. 63-80.
10.1007/s00401-020-02156-4.
|
|
Neerland, BE;
Halaas, NB;
Idland, AV;
Henjum, K;
Blennow, K;
Zetterberg, H;
Watne, LO;
(2020)
Fatty Acid-Binding Protein 3 in Cerebrospinal Fluid of Hip Fracture Patients with Delirium.
Journal of Alzheimer's Disease
, 77
(1)
pp. 183-190.
10.3233/JAD-200364.
|
|
|
Neth, BJ;
Mintz, A;
Whitlow, C;
Jung, Y;
Solingapuram Sai, K;
Register, TC;
Kellar, D;
... Craft, S; + view all
(2020)
Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer's disease: a pilot study.
Neurobiology of Aging
, 86
pp. 54-63.
10.1016/j.neurobiolaging.2019.09.015.
|
|
Ng, J;
Cortès-Saladelafont, E;
Abela, L;
Termsarasab, P;
Mankad, K;
Sudhakar, S;
Gorman, KM;
... Kurian, MA; + view all
(2020)
DNAJC6 Mutations Disrupt Dopamine Homeostasis in Juvenile Parkinsonism‐Dystonia.
Movement Disorders
10.1002/mds.28063.
(In press).
|
|
|
Noorani, I;
de la Rosa, J;
Choi, Y;
Strong, A;
Ponstingl, H;
Vijayabaskar, MS;
Lee, J;
... Bradley, A; + view all
(2020)
PiggyBac mutagenesis and exome sequencing identify genetic driver landscapes and potential therapeutic targets of EGFR-mutant gliomas.
Genome Biology
, 21
, Article 181. 10.1186/s13059-020-02092-2.
|
|
|
Norsworthy, PJ;
Thompson, AGB;
Mok, TH;
Guntoro, F;
Dabin, LC;
Nihat, A;
Paterson, RW;
... Viré, EA; + view all
(2020)
A blood miRNA signature associates with sporadic Creutzfeldt-Jakob disease diagnosis.
Nature Communications
, 11
(1)
, Article 3960. 10.1038/s41467-020-17655-x.
|
|
|
Novakova, L;
Axelsson, M;
Malmeström, C;
Zetterberg, H;
Blennow, K;
Svenningsson, A;
Lycke, J;
(2020)
NFL and CXCL13 may reveal disease activity in clinically and radiologically stable MS.
Multiple Sclerosis and Related Disorders
, 46
, Article 102463. 10.1016/j.msard.2020.102463.
|
|
Noyce, A;
(2020)
Parkinson’s disease determinants, prediction and gene-environment interactions in the UK Biobank.
Journal of Neurology, Neurosurgery and Psychiatry
, 91
(10)
pp. 1046-1054.
10.1136/jnnp-2020-323646.
|
|
Nyberg, L;
Lundquist, A;
Nordin Adolfsson, A;
Andersson, M;
Zetterberg, H;
Blennow, K;
Adolfsson, R;
(2020)
Elevated plasma neurofilament light in aging reflects brain white-matter alterations but does not predict cognitive decline or Alzheimer's disease.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 12
(1)
, Article e12050. 10.1002/dad2.12050.
|
|
O
|
O'Brien, J;
Taylor, JP;
Ballard, C;
Barker, RA;
Bradley, C;
Burns, A;
Collerton, D;
... Ffytche, D; + view all
(2020)
Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2019-322702.
(In press).
|
|
|
O'Connor, A;
Karikari, TK;
Poole, T;
Ashton, NJ;
Rodriguez, JL;
Khatun, A;
Swift, I;
... Fox, NC; + view all
(2020)
Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer's disease: a longitudinal cohort study.
Molecular Psychiatry
10.1038/s41380-020-0838-x.
(In press).
|
|
O'Connor, A;
Weston, PSJ;
Pavisic, IM;
Ryan, NS;
Collins, JD;
Lu, K;
Crutch, SJ;
... Oxtoby, NP; + view all
(2020)
Quantitative detection and staging of presymptomatic cognitive decline in familial Alzheimer’s disease: a retrospective cohort analysis.
Alzheimer's Research & Therapy
, 12
, Article 126. 10.1186/s13195-020-00695-2.
|
|
|
O'Shaughnessy, NJ;
Chan, JE;
Bhome, R;
Gallagher, P;
Zhang, H;
Clare, L;
Sampson, EL;
... Huntley, J; + view all
(2020)
Awareness in severe Alzheimer’s disease: a systematic review.
Aging & Mental Health
10.1080/13607863.2020.1711859.
(In press).
|
|
|
O’Regan, GC;
Farag, SH;
Ostroff, GR;
Tabrizi, SJ;
Andre, R;
(2020)
Wild-type huntingtin regulates human macrophage function.
Scientific Reports
, 10
(1)
, Article 17269. 10.1038/s41598-020-74042-8.
|
|
|
Obrocki, P;
Khatun, A;
Ness, D;
Senkevich, K;
Hanrieder, J;
Capraro, F;
Mattsson, N;
... Zetterberg, H; + view all
(2020)
Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course-a joint PhD student course at University College London and University of Gothenburg.
Alzheimer's Research & Therapy
, 12
(1)
, Article 20. 10.1186/s13195-020-00586-6.
|
|
|
Ohrfelt, A;
Dumurgier, J;
Zetterberg, H;
Vrillon, A;
Ashton, NJ;
Kvartsberg, H;
Bouaziz-Amar, E;
... Blennow, K; + view all
(2020)
Full-length and C-terminal neurogranin in Alzheimer's disease cerebrospinal fluid analyzed by novel ultrasensitive immunoassays.
Alzheimer's Research & Therapy
, 12
, Article 168. 10.1186/s13195-020-00748-6.
|
|
|
Onatsu, J;
Vanninen, R;
Jäkälä, P;
Mustonen, P;
Pulkki, K;
Korhonen, M;
Hedman, M;
... Taina, M; + view all
(2020)
Tau, S100B and NSE as Blood Biomarkers in Acute Cerebrovascular Events.
In Vivo
, 34
(5)
pp. 2577-2586.
10.21873/invivo.12075.
|
|
|
Opladen, T;
López-Laso, E;
Cortès-Saladelafont, E;
Pearson, TS;
Sivri, HS;
Yildiz, Y;
Assmann, B;
... International Working Group on Neurotransmitter related Disorder, .; + view all
(2020)
Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH₄) deficiencies.
Orphanet Journal of Rare Diseases
, 15
(1)
, Article 126. 10.1186/s13023-020-01379-8.
|
|
|
Orme, T;
Hernandez, D;
Ross, OA;
Kun-Rodrigues, C;
Darwent, L;
Shepherd, CE;
Parkkinen, L;
... Bras, J; + view all
(2020)
Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies.
Acta Neuropathologica Communications
, 8
(1)
, Article 5. 10.1186/s40478-020-0879-z.
|
|
|
Ou, ZYA;
Byrne, LM;
Rodrigues, FB;
Tortelli, R;
Johnson, EB;
Foiani, MS;
Arridge, M;
... Wild, EJ; + view all
(2020)
Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington's disease.
MedRxiv: Cold Spring Harbor, NY, USA.
|
|
P
|
Palmqvist, S;
Janelidze, S;
Quiroz, YT;
Zetterberg, H;
Lopera, F;
Stomrud, E;
Su, Y;
... Hansson, O; + view all
(2020)
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.
JAMA
10.1001/jama.2020.12134.
(In press).
|
|
Papoutsi, M;
Magerkurth, J;
Josephs, O;
Pépés, SE;
Ibitoye, T;
Reilmann, R;
Hunt, N;
... Tabrizi, SJ; + view all
(2020)
Activity or connectivity? A randomized controlled feasibility study evaluating neurofeedback training in Huntington's disease.
Brain Communications
10.1093/braincomms/fcaa049.
(In press).
|
|
|
Parbo, P;
Madsen, LS;
Ismail, R;
Zetterberg, H;
Blennow, K;
Eskildsen, SF;
Vorup-Jensen, T;
(2020)
Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer's disease.
Alzheimer's Research & Therapy
, 12
, Article 3. 10.1186/s13195-019-0574-0.
|
|
|
Park, YH;
Hodges, A;
Simmons, A;
Lovestone, S;
Weiner, MW;
Kim, SY;
Saykin, AJ;
... Hsiao, J; + view all
(2020)
Association of blood-based transcriptional risk scores with biomarkers for Alzheimer disease.
Neurology: Genetics
, 6
(6)
, Article e517. 10.1212/NXG.0000000000000517.
|
|
|
Parker, T;
Cash, DM;
Lane, C;
Lu, K;
Malone, IB;
Nicholas, JM;
James, S;
... Schott, JM; + view all
(2020)
Pure tone audiometry and cerebral pathology in healthy older adults.
Journal of Neurology, Neurosurgery & Psychiatry
, 91
(2)
pp. 172-176.
10.1136/jnnp-2019-321897.
|
|
Parker, TD;
Cash, DM;
Lane, CA;
Lu, K;
Malone, IB;
Nicholas, JM;
James, S;
... Schott, JM; + view all
(2020)
Amyloid β influences the relationship between cortical thickness and vascular load.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 12
(1)
, Article e12022. 10.1002/dad2.12022.
|
|
|
Paterson, RW;
Brown, RL;
Benjamin, L;
Nortley, R;
Wiethoff, S;
Bharucha, T;
Jayaseelan, DL;
... UCL Queen Square National Hospital for Neurology and Neurosurger; + view all
(2020)
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings.
Brain
10.1093/brain/awaa240.
(In press).
|
|
|
Pavisic, IM;
Nicholas, JM;
O'Connor, A;
Rice, H;
Lu, K;
Fox, NC;
Ryan, NS;
(2020)
Disease duration in autosomal dominant familial Alzheimer disease.
Neurology Genetics
, 6
(5)
, Article e507. 10.1212/nxg.0000000000000507.
|
|
|
Pavisic, IM;
Suarez-Gonzalez, A;
Pertzov, Y;
(2020)
Translating Visual Short-Term Memory Binding Tasks to Clinical Practice: From Theory to Practice.
Frontiers in Neurology
, 11
, Article 458. 10.3389/fneur.2020.00458.
|
|
|
Peakman, G;
Karunatilake, N;
Seynaeve, M;
Perera, G;
Aarsland, D;
Stewart, R;
Mueller, C;
(2020)
Clinical factors associated with progression to dementia in people with late-life depression: a cohort study of patients in secondary care.
BMJ Open
, 10
(5)
, Article e035147. 10.1136/bmjopen-2019-035147.
|
|
|
Pelegrini, LNDC;
Hall, A;
Hooper, E;
Oliveira, D;
Guerra, F;
Casemiro, FG;
Bonfadini, J;
... Mioshi, E; + view all
(2020)
Challenges in public perception: highlights from the United Kingdom-Brazil Dementia Workshop.
Dementia & Neuropsychologia
, 14
(3)
pp. 209-215.
10.1590/1980-57642020dn14-030002.
|
|
|
Peluso, MJ;
Thanh, C;
Prator, CA;
Hogan, LE;
Arechiga, VM;
Stephenson, S;
Norris, PJ;
... Henrich, TJ; + view all
(2020)
Cerebrospinal fluid soluble CD30 elevation despite suppressive antiretroviral therapy in individuals living with HIV-1.
Journal of Virus Eradication
, 6
(1)
pp. 19-26.
|
|
|
Pereira, JB;
Janelidze, S;
Ossenkoppele, R;
Kvartsberg, H;
Brinkmalm, A;
Mattsson-Carlgren, N;
Stomrud, E;
... Hansson, O; + view all
(2020)
Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease.
Brain
10.1093/brain/awaa395.
(In press).
|
|
|
Petzold, A;
Lu, C-H;
Groves, M;
Gobom, J;
Zetterberg, H;
Shaw, G;
O'Connor, S;
(2020)
Protein aggregate formation permits millennium-old brain preservation.
Journal of the Royal Society Interface
, 17
(162)
, Article 20190775. 10.1098/rsif.2019.0775.
|
|
|
Pick, S;
Hodsoll, J;
Stanton, B;
Eskander, A;
Stavropoulos, I;
Samra, K;
Bottini, J;
... Nicholson, TR; + view all
(2020)
Trial Of Neurostimulation In
Conversion Symptoms (TONICS): a
feasibility randomised controlled trial
of transcranial magnetic stimulation for
functional limb weakness.
BMJ Open
, 10
(10)
, Article e037198. 10.1136/bmjopen-2020-037198.
|
|
|
Pilotto, A;
Odolini, S;
Stefano Masciocchi, S;
Comelli, A;
Volonghi, I;
Gazzina, S;
Nocivelli, S;
... Padovani, A; + view all
(2020)
Steroid-Responsive Encephalitis in Coronavirus Disease 2019.
Annals of Neurology
, 88
(2)
pp. 423-427.
10.1002/ana.25783.
|
|
Piras, IS;
Bleul, C;
Schrauwen, I;
Talboom, J;
Llaci, L;
De Both, MD;
Naymik, MA;
... Huentelman, MJ; + view all
(2020)
Transcriptional profiling of Multiple System Atrophy cerebellar tissue highlights differences between the parkinsonian and cerebellar sub-types of the disease.
BioRxiv: Cold Spring Harbor, NY, USA.
|
|
|
Piras, IS;
Bleul, C;
Schrauwen, I;
Talboom, J;
Llaci, L;
De Both, MD;
Naymik, MA;
... Huentelman, MJ; + view all
(2020)
Transcriptional profiling of multiple system atrophy cerebellar tissue highlights differences between the parkinsonian and cerebellar sub-types of the disease.
Acta Neuropathologica Communications
, 8
, Article 76. 10.1186/s40478-020-00950-5.
|
|
|
Poos, Jackie M;
Russell, Lucy L;
Peakman, Georgia;
Moore, Katrina M;
Greaves, Caroline V;
Bocchetta, Martina;
Jiskoot, Lize C;
... Rohrer, Jonathan D; + view all
(2020)
The Free Cued Selective Reminding Test detects episodic memory impairment in the presymptomatic period of familial frontotemporal dementia within the GENFI cohort.
Presented at: UNSPECIFIED.
|
|
Posti, JP;
Takala, RSK;
Raj, R;
Luoto, TM;
Azurmendi, L;
Lagerstedt, L;
Mohammadian, M;
... Sanchez, JC; + view all
(2020)
Admission Levels of Interleukin 10 and Amyloid β 1–40 Improve the Outcome Prediction Performance of the Helsinki Computed Tomography Score in Traumatic Brain Injury.
Frontiers in Neurology
, 11
, Article 549527. 10.3389/fneur.2020.549527.
|
|
|
Preza, Elisavet;
(2020)
Stem cell models of C9orf72-linked Frontotemporal Dementia.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
|
Primativo, S;
Crutch, S;
Pavisic, I;
Yong, K;
Rossetti, A;
Daini, R;
(2020)
Impaired mechanism of visual focal attention in posterior cortical atrophy.
Neuropsychology
, 34
(7)
pp. 799-810.
10.1037/neu0000697.
|
|
|
Prudencio, M;
Humphrey, J;
Pickles, S;
Brown, A-L;
Hill, SE;
Kachergus, J;
Shi, J;
... Petrucelli, L; + view all
(2020)
Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia.
Journal of Clinical Investigation
10.1172/JCI139741.
(In press).
|
|
Q
|
Quaegebeur, A;
Glaria, I;
Lashley, T;
Isaacs, AM;
(2020)
Soluble and insoluble dipeptide repeat protein measurements in C9orf72-frontotemporal dementia brains show regional differential solubility and correlation of poly-GR with clinical severity.
Acta Neuropathologica Communications
, 8
(1)
, Article 184. 10.1186/s40478-020-01036-y.
|
|
|
Quiroz, YT;
Zetterberg, H;
Reiman, EM;
Chen, Y;
Su, Y;
Fox-Fuller, JT;
Garcia, G;
... Lopera, F; + view all
(2020)
Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study.
The Lancet Neurology
, 19
(6)
pp. 513-521.
10.1016/S1474-4422(20)30137-X.
|
R
|
Rajewsky, N;
Almouzni, G;
Gorski, SA;
Aerts, S;
Amit, I;
Bertero, MG;
Bock, C;
... LifeTime Community; + view all
(2020)
LifeTime and improving European healthcare through cell-based interceptive medicine.
Nature
10.1038/s41586-020-2715-9.
(In press).
|
|
|
Raket, LL;
Kühnel, L;
Schmidt, E;
Blennow, K;
Zetterberg, H;
Mattsson-Carlgren, N;
(2020)
Utility of plasma neurofilament light and total tau for clinical trials in Alzheimer's disease.
lzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 12
(1)
, Article e12099. 10.1002/dad2.12099.
|
|
|
Rees, J;
Solomons, M;
Weil, R;
Jaunmuktane, Z;
Brandner, S;
El-Hassan, T;
(2020)
Seizure outcomes and survival in adult low-grade glioma over 11 years: living longer and better.
Neuro-Oncology Practice
, 7
(2)
pp. 196-201.
10.1093/nop/npz056.
|
|
Reiman, EM;
Arboleda-Velasquez, JF;
Quiroz, YT;
Huentelman, MJ;
Beach, TG;
Caselli, RJ;
Chen, Y;
... Alzheimer’s Disease Genetics Consortium; + view all
(2020)
Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study.
Nature Communications
, 11
, Article 667. 10.1038/s41467-019-14279-8.
|
|
|
Reinert, LS;
Rashidi, AS;
Tran, DN;
Katzilieris-Petras, G;
Hvidt, AK;
Gohr, M;
Fruhwürth, S;
... Paluden, SR; + view all
(2020)
Brain immune cells undergo cGAS-STING-dependent apoptosis during herpes simplex virus type 1 infection.
Journal of Clinical Investigation
10.1172/JCI136824.
(In press).
|
|
|
Rendina, A;
Drongitis, D;
Donizetti, A;
Fucci, L;
Milan, G;
Tripodi, F;
Giustezza, F;
... Vitale, E; + view all
(2020)
CD33 and SIGLECL1 Immunoglobulin Superfamily Involved in Dementia.
Journal of Neuropathology & Experimental Neurology
, 79
(8)
pp. 891-901.
10.1093/jnen/nlaa055.
|
|
Requena-Komuro, M-C;
Marshall, CR;
Bond, RL;
Russell, LL;
Greaves, C;
Moore, KM;
Agustus, JL;
... Warren, JD; + view all
(2020)
Altered Time Awareness in Dementia.
Frontiers in Neurology
, 11
, Article 291. 10.3389/fneur.2020.00291.
|
|
|
Ricci, B;
Millner, TO;
Pomella, N;
Zhang, X;
Guglielmi, L;
Badodi, S;
Ceric, D;
... Marino, S; + view all
(2020)
Polycomb-mediated repression of EphrinA5 promotes growth and invasion of glioblastoma.
Oncogene
10.1038/s41388-020-1161-3.
(In press).
|
|
|
Roberts, SL;
Evans, T;
Yang, Y;
Fu, Y;
Button, RW;
Sipthorpe, RJ;
Cowan, K;
... Luo, S; + view all
(2020)
Bim contributes to the progression of Huntington's disease-associated phenotypes.
Human Molecular Genetics
, 29
(2)
pp. 216-227.
10.1093/hmg/ddz275.
|
|
|
Roberts, TA;
Hyare, H;
Agliardi, G;
Hipwell, B;
d'Esposito, A;
Ianus, A;
Breen-Norris, JO;
... Walker-Samuel, S; + view all
(2020)
Noninvasive diffusion magnetic resonance imaging of brain tumour cell size for the early detection of therapeutic response.
Scientific Reports
, 10
, Article 9223. 10.1038/s41598-020-65956-4.
|
|
|
Rodrigues, FB;
Duarte, GS;
Marques, RE;
Castelão, M;
Ferreira, J;
Sampaio, C;
Moore, AP;
(2020)
Botulinum toxin type A therapy for cervical dystonia.
Cochrane Database of Systematic Reviews
, 11
, Article CD003633. 10.1002/14651858.CD003633.pub4.
|
|
Rodrigues, FB;
Ferreira, JJ;
(2020)
Chapter Three - Strategies to minimize placebo effects in research investigations.
International Review of Neurobiology
, 153
pp. 49-70.
10.1016/bs.irn.2020.04.002.
|
|
Rodrigues, FB;
Wild, EJ;
(2020)
Huntington's Disease Clinical Trials Corner: April 2020.
Journal of Huntington's Disease
, 9
(2)
pp. 185-197.
10.3233/JHD-200002.
|
|
|
Rosas, I;
Martínez, C;
Clarimón, J;
Lleó, A;
Illán-Gala, I;
Dols-Icardo, O;
Borroni, B;
... Menéndez-González, M; + view all
(2020)
Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer's disease.
Neurobiology of Aging
, 87
139.e1-139.e7.
10.1016/j.neurobiolaging.2019.10.017.
|
|
Rosén, A;
Gennser, M;
Oscarsson, N;
Kvarnström, A;
Sandström, G;
Blennow, K;
Seeman-Lodding, H;
(2020)
Biomarkers of neuronal damage in saturation diving-a controlled observational study.
European Journal of Applied Physiology
10.1007/s00421-020-04499-y.
(In press).
|
|
|
Rossor, M;
(2020)
A 2020 vision for JNNP.
Journal of Neurology, Neurosurgery and Psychiatry
, 91
(3)
pp. 225-226.
10.1136/jnnp-2019-321981.
|
|
|
Rossor, M;
(2020)
One hundred years of shared interest.
J Neurol Neurosurg Psychiatry
, 91
(3)
pp. 225-226.
10.1136/jnnp-2019-321981.
|
|
|
Russell, LL;
Greaves, CV;
Bocchetta, M;
Nicholas, J;
Convery, RS;
Moore, K;
Cash, DM;
... Anderl-Straub, S; + view all
(2020)
Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort.
Cortex
10.1016/j.cortex.2020.08.023.
(In press).
|
|
S
|
S Silva, C;
Brogueira Rodrigues, F;
S Duarte, G;
Costa, J;
Carvalho, MD;
(2020)
Prognostic value of phrenic nerve conduction study in amyotrophic lateral sclerosis: systematic review and meta-analysis.
Journal of Clinical Neurophysiology
, 131
(1)
pp. 106-113.
10.1016/j.clinph.2019.10.016.
|
|
Saddiki, H;
Fayosse, A;
Cognat, E;
Sabia, S;
Engelborghs, S;
Wallon, D;
Alexopoulos, P;
... Dumurgier, J; + view all
(2020)
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
PLOS Medicine
, 17
(8)
, Article e1003289. 10.1371/journal.pmed.1003289.
|
|
|
Sajjad, MU;
Blennow, K;
Knapskog, AB;
Idland, A-V;
Chaudhry, FA;
Wyller, TB;
Zetterberg, H;
(2020)
Cerebrospinal Fluid Levels of Interleukin-8 in Delirium, Dementia, and Cognitively Healthy Patients.
Journal of Alzheimer's Disease
10.3233/JAD-190941.
(In press).
|
|
Sampson, EL;
Anderson, J;
Candy, B;
Davies, N;
Ellis-Smith, C;
Gola, A;
Harding, R;
... Evans, CJ; + view all
(2020)
Empowering Better End‐of‐Life Dementia Care (EMBED‐Care): A mixed methods protocol to achieve integrated person‐centred care across settings.
International Journal of Geriatric Psychiatry
10.1002/gps.5251.
(In press).
|
|
|
Samra, K;
Rogers, J;
Mahdi-Rogers, M;
Stanton, B;
(2020)
Catatonia with GABAA receptor antibodies.
Practical Neurology
, 20
(2)
pp. 139-143.
10.1136/practneurol-2019-002388.
|
|
Sandberg, A;
Ling, H;
Gearing, M;
Dombroski, B;
Cantwell, L;
R'Bibo, L;
Levey, A;
... Mok, KY; + view all
(2020)
Fibrillation and molecular characteristics are coherent with clinical and pathological features of 4-repeat tauopathy caused by MAPT variant G273R.
Neurobiology of Disease
, 146
, Article 105079. 10.1016/j.nbd.2020.105079.
|
|
|
Santos-Mandujano, RA;
Ryan, NS;
Chávez-Gutiérrez, L;
Sánchez-Torres, C;
Meraz-Ríos, MA;
(2020)
Clinical Association of White Matter Hyperintensities Localization in a Mexican Family with Spastic Paraparesis Carrying the PSEN1 A431E Mutation.
Journal of Alzheimer's Disease
, 73
(3)
pp. 1075-1083.
10.3233/JAD-190978.
|
|
Sardone, R;
Battista, P;
Donghia, R;
Lozupone, M;
Tortelli, R;
Guerra, V;
Grasso, A;
... Quaranta, N; + view all
(2020)
Age-Related Central Auditory Processing Disorder, MCI, and Dementia in an Older Population of Southern Italy.
Otolaryngology–Head and Neck Surgery
, 163
(2)
pp. 348-355.
10.1177/0194599820913635.
|
|
|
Satir, TM;
Agholme, L;
Karlsson, A;
Karlsson, M;
Karila, P;
Illes, S;
Bergström, P;
(2020)
Partial reduction of amyloid β production by β-secretase inhibitors does not decrease synaptic transmission.
Alzheimer's Research & Therapy
, 12
, Article 63. 10.1186/s13195-020-00635-0.
|
|
|
Satir, TM;
Nazir, FH;
Vizlin-Hodzic, D;
Hardselius, E;
Blennow, K;
Wray, S;
Zetterberg, H;
... Bergström, P; + view all
(2020)
Accelerated neuronal and synaptic maturation by BrainPhys medium increases Aβ secretion and alters Aβ peptide ratios from iPSC-derived cortical neurons.
Scientific Reports
, 10
, Article 601. 10.1038/s41598-020-57516-7.
|
|
|
Scaglioni, D;
Ellis, M;
Catapano, F;
Torelli, S;
Chambers, D;
Feng, L;
Sewry, C;
... Phadke, R; + view all
(2020)
A high–throughput digital script for multiplexed immunofluorescent analysis and quantification of sarcolemmal and sarcomeric proteins in muscular dystrophies.
Acta Neuropathologica Communications
, 8
, Article 53. 10.1186/s40478-020-00918-5.
|
|
|
Scahill, RI;
Zeun, P;
Osborne-Crowley, K;
Johnson, EB;
Gregory, S;
Parker, C;
Lowe, J;
... Tabrizi, SJ; + view all
(2020)
Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis.
The Lancet Neurology
, 19
(6)
pp. 502-512.
10.1016/S1474-4422(20)30143-5.
|
|
|
Schito, P;
Ceccardi, G;
Calvo, A;
Falzone, YM;
Moglia, C;
Lunetta, C;
Marinou, K;
... Filippi, M; + view all
(2020)
Clinical features and outcomes of the flail arm and flail leg and pure lower motor neuron MND variants: a multicentre Italian study.
Journal of Neurology, Neurosurgery & Psychiatry
, 91
(9)
pp. 1001-1003.
10.1136/jnnp-2020-323542.
|
|
Schöll, M;
Maass, A;
(2020)
Does early cognitive decline require the presence of both tau and amyloid-β?
Brain
, 143
(1)
pp. 10-13.
10.1093/brain/awz399.
|
|
Schottlaender, LV;
Abeti, R;
Jaunmuktane, Z;
Macmillan, C;
Chelban, V;
O'Callaghan, B;
McKinley, J;
... Houlden, H; + view all
(2020)
Bi-allelic JAM2 Variants Lead to Early-Onset Recessive Primary Familial Brain Calcification.
AJHG
, 106
(3)
pp. 412-421.
10.1016/j.ajhg.2020.02.007.
|
|
|
Schultz, SA;
Strain, JF;
Adedokun, A;
Wang, Q;
Preische, O;
Kuhle, J;
Flores, S;
... Dominantly Inherited Alzheimer Network; + view all
(2020)
Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease.
Neurobiology of Disease
, 142
, Article 104960. 10.1016/j.nbd.2020.104960.
|
|
|
Scrutinio, D;
Battista, P;
Guida, P;
Lanzillo, B;
Tortelli, R;
(2020)
Sex Differences in Long-Term Mortality and Functional Outcome After Rehabilitation in Patients With Severe Stroke.
Frontiers in Neurology
, 11
, Article 84. 10.3389/fneur.2020.00084.
|
|
|
Shadrin, AA;
Mucha, S;
Ellinghaus, D;
Makarious, MB;
Blauwendraat, C;
Sreelatha, AAK;
Heras-Garvin, A;
... Sharma, M; + view all
(2020)
Shared Genetics of Multiple System Atrophy and Inflammatory Bowel Disease.
Movement Disorders
10.1002/mds.28338.
(In press).
|
|
|
Shahim, P;
Gill, JM;
Blennow, K;
Zetterberg, H;
(2020)
Fluid Biomarkers for Chronic Traumatic Encephalopathy.
Seminars in Neurology
, 40
(4)
pp. 411-419.
10.1055/s-0040-1715095.
|
|
Shahim, P;
Politis, A;
van der Merwe, A;
Moore, B;
Chou, Y-Y;
Pham, DL;
Butman, JA;
... Chan, L; + view all
(2020)
Neurofilament Light as a Biomarker in Traumatic Brain Injury.
Neurology
, 95
(6)
e610-e622.
10.1212/WNL.0000000000009983.
|
|
Shahim, P;
Politis, A;
van der Merwe, A;
Moore, B;
Ekanayake, V;
Lippa, S;
Chou, Y-Y;
... Chan, L; + view all
(2020)
Time course and diagnostic utility of NfL, tau, GFAp, and UCH-L1 in subacute and chronic TBI.
Neurology
, 95
(6)
e623-e636.
10.1212/WNL.0000000000009985.
|
|
Shams, M;
Martola, J;
Charidimou, A;
Granberg, T;
Ferreira, D;
Westman, E;
Wintermark, M;
... Shams, S; + view all
(2020)
Cerebrospinal Fluid Metals and the Association with Cerebral Small Vessel Disease.
Journal of Alzheimer's Disease
10.3233/JAD-200656.
(In press).
|
|
|
Shapey, J;
Xie, Y;
Nabavi, E;
Ebner, M;
Maneas, E;
Saeed, SR;
Dorward, N;
... Vercauteren, T; + view all
(2020)
Ex vivo assessment of the optical characteristics of human brain and tumour tissue.
In:
SPIE Proceedings - Label-free Biomedical Imaging and Sensing (LBIS) 2020.
(pp. 112510J-112510J).
SPIE: San Francisco, CA, USA.
|
|
|
Shen, X;
Ma, S;
Vemuri, P;
Simon, G;
Alzheimer’s Disease Neuroimaging Initiative, .;
(2020)
Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer's Pathophysiology.
Scientific Reports
, 10
(1)
, Article 2975. 10.1038/s41598-020-59669-x.
|
|
|
Shi, L;
Winchester, LM;
Liu, BY;
Killick, R;
Ribe, EM;
Westwood, S;
Baird, AL;
... Lovestone, S; + view all
(2020)
Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.
Journal of Alzheimer's Disease
10.3233/JAD-200208.
(In press).
|
|
|
Shribman, S;
Heller, C;
Burrows, M;
Heslegrave, A;
Swift, I;
Foiani, MS;
Gillett, GT;
... Warner, TT; + view all
(2020)
Plasma Neurofilament Light as a Biomarker of Neurological Involvement in Wilson's Disease.
Movement Disorders
10.1002/mds.28333.
(In press).
|
|
|
Sievers, P;
Schrimpf, D;
Stichel, D;
Reuss, DE;
Hasselblatt, M;
Hagel, C;
Staszewski, O;
... Jones, DTW; + view all
(2020)
Posterior fossa pilocytic astrocytomas with oligodendroglial features show frequent FGFR1 activation via fusion or mutation.
Acta Neuropathologica
, 139
pp. 403-406.
10.1007/s00401-019-02097-7.
|
|
Sievers, P;
Sill, M;
Blume, C;
Tauziede-Espariat, A;
Schrimpf, D;
Stichel, D;
Reuss, DE;
... German Consortium “Aggressive Meningiomas”; + view all
(2020)
Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1.
Acta Neuropathologica
10.1007/s00401-020-02247-2.
(In press).
|
|
|
Skouras, S;
Torner, J;
Andersson, P;
Koush, Y;
Falcon, C;
Minguillon, C;
Fauria, K;
... ALFA Study; + view all
(2020)
Earliest amyloid and tau deposition modulate the influence of limbic networks during closed-loop hippocampal downregulation.
Brain
10.1093/brain/awaa011.
(In press).
|
|
Smith, AV;
Tabrizi, SJ;
(2020)
Therapeutic Antisense Targeting of Huntingtin.
DNA and Cell Biology
, 39
(2)
pp. 154-158.
10.1089/dna.2019.5188.
|
|
Smith, KA;
Bradbury, K;
Essery, R;
Pollet, S;
Mowbray, F;
Slodkowska-Barabasz, J;
Denison-Day, J;
... Yardley, L; + view all
(2020)
The Active Brains Digital Intervention to Reduce Cognitive Decline in Older Adults: Protocol for a Feasibility Randomized Controlled Trial.
JMIR Research Protocols
, 9
(11)
, Article e18929. 10.2196/18929.
|
|
|
Sng, Letitia MF;
Thomson, Peter C;
Trabzuni, Daniah;
(2020)
Comparison Between Expression Microarrays and RNA-Sequencing Using UKBEC Dataset Identified a trans-eQTL Associated with MPZ Gene in Substantia Nigra.
Advances in Neurology and Neuroscience Research
, 1
, Article 100001.
|
|
|
Spotorno, N;
Lindberg, O;
Nilsson, C;
Landqvist Waldö, M;
Van Westen, D;
Nilsson, K;
Vestberg, S;
... Alexander, S; + view all
(2020)
Plasma neurofilament light protein correlates with diffusion tensor imaging metrics in frontotemporal dementia.
PLOS ONE
, 15
(10)
, Article e0236384. 10.1371/journal.pone.0236384.
|
|
|
Squillario, M;
Abate, G;
Tomasi, F;
Tozzo, V;
Barla, A;
Uberti, D;
Alzheimer’s Disease Neuroimaging Initiative;
(2020)
A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer's disease.
Scientific Reports
, 10
(1)
, Article 12063. 10.1038/s41598-020-67699-8.
|
|
|
Startin, CM;
D'Souza, H;
Ball, G;
Hamburg, S;
Hithersay, R;
Hughes, KMO;
Massand, E;
... Strydom, A; + view all
(2020)
Health comorbidities and cognitive abilities across the lifespan in Down syndrome.
Journal of Neurodevelopmental Disorders
, 12
, Article 4. 10.1186/s11689-019-9306-9.
|
|
|
Stoner, CR;
Knapp, M;
Luyten, J;
Kung, C;
Richards, M;
Long, R;
Rossor, M;
(2020)
The cognitive footprint of medication: A review of cognitive assessments in clinical trials.
Journal of Clinical Pharmacy and Therapeutics
10.1111/jcpt.13151.
(In press).
|
|
|
Suárez-Calvet, M;
Karikari, TK;
Ashton, NJ;
Lantero Rodríguez, J;
Milà-Alomà, M;
Gispert, JD;
Salvadó, G;
... ALFA Study; + view all
(2020)
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detected.
EMBO Molecular Medicine
, Article e12921. 10.15252/emmm.202012921.
(In press).
|
|
|
Suárez-González, A;
Zimmermann, N;
Waddington, C;
Wood, O;
Harding, E;
Brotherhood, E;
Fox, NC;
(2020)
Non-memory led dementias: care in the time of covid-19.
The British Medical Journal
, 369
, Article m2489. 10.1136/bmj.m2489.
|
|
|
Suárez-Pinilla, P;
Pérez-Herrera, M;
Suárez-Pinilla, M;
Medina-Blanco, R;
López-García, E;
Artal-Simón, JÁ;
de Santiago-Díaz, AI;
(2020)
Recurrence of suicidal thoughts and behaviors during one year of follow-up: An exploratory study.
Psychiatry Research
, 288
, Article 112988. 10.1016/j.psychres.2020.112988.
|
|
Subramanian, ML;
Vig, V;
Chung, J;
Fiorello, MG;
Xia, W;
Zetterberg, H;
Blennow, K;
... Stein, TD; + view all
(2020)
Neurofilament light chain in the vitreous humor of the eye.
Alzheimer's Research & Therapy
, 12
, Article 111. 10.1186/s13195-020-00677-4.
|
|
|
Sudre, CH;
Panovska-Griffiths, J;
Sanverdi, E;
Brandner, S;
Katsaros, VK;
Stranjalis, G;
Pizzini, FB;
... Bisdas, S; + view all
(2020)
Machine learning assisted DSC-MRI radiomics as a tool for glioma classification by grade and mutation status.
BMC Medical Informatics and Decision Making
, 20
, Article 149. 10.1186/s12911-020-01163-5.
|
|
|
Sugarman, MA;
Zetterberg, H;
Blennow, K;
Tripodis, Y;
McKee, AC;
Stein, TD;
Martin, B;
... Alosco, ML; + view all
(2020)
A longitudinal examination of plasma neurofilament light and total tau for the clinical detection and monitoring of Alzheimer's disease.
Neurobiology of Aging
, 94
pp. 60-70.
10.1016/j.neurobiolaging.2020.05.011.
|
|
Sur, C;
Kost, J;
Scott, D;
Adamczuk, K;
Fox, NC;
Cummings, JL;
Tariot, PN;
... Egan, MF; + view all
(2020)
BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain.
Brain
, 143
(12)
pp. 3816-3826.
10.1093/brain/awaa332.
|
|
Swift, I;
Bocchetta, M;
Benotmane, H;
Woollacott, IOC;
Shafei, R;
Rohrer, JD;
(2020)
Variable clinical phenotype in TBK1 mutations: case report of a novel mutation causing primary progressive aphasia and review of the literature.
Neurobiology of Aging
10.1016/j.neurobiolaging.2020.08.014.
(In press).
|
|
|
Swift, IJ;
Sogorb-Esteve, A;
Heller, C;
Synofzik, M;
Otto, M;
Graff, C;
Galimberti, D;
... Rohrer, JD; + view all
(2020)
Fluid biomarkers in frontotemporal dementia: past, present and future.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2020-323520.
(In press).
|
|
T
|
Tabrizi, SJ;
Flower, MD;
Ross, CA;
Wild, EJ;
(2020)
Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities.
Nature Reviews Neurology
, 16
pp. 529-546.
10.1038/s41582-020-0389-4.
|
|
Taghdiri, F;
Multani, N;
Ozzoude, M;
Tarazi, A;
Khodadadi, M;
Wennberg, R;
Mikulis, D;
... Tartaglia, MC; + view all
(2020)
Neurofilament-Light in Former Athletes: A Potential Biomarker of Neurodegeneration and Progression.
European Journal of Neurology
, 27
(7)
pp. 1170-1177.
10.1111/ene.14251.
|
|
Tan, MMX;
Lawton, MA;
Jabbari, E;
Reynolds, RH;
Iwaki, H;
Blauwendraat, C;
Kanavou, S;
... Morris, HR; + view all
(2020)
Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson's Disease.
Movement Disorders
10.1002/mds.28342.
(In press).
|
|
|
Tanabe, S;
Bo, A;
White, M;
Parker, M;
Farahbakhsh, Z;
Ballweg, T;
Casey, C;
... Sanders, RD; + view all
(2020)
Cohort study of electroencephalography markers of amyloid-tau-neurodegeneration pathology.
Brain Communications
, 2
(2)
, Article fcaa099. 10.1093/braincomms/fcaa099.
|
|
|
Tavares, TP;
Mitchell, DG;
Coleman, KKL;
Coleman, BL;
Shoesmith, CL;
Butler, CR;
Santana, I;
... Finger, E; + view all
(2020)
Early symptoms in symptomatic and preclinical genetic frontotemporal lobar degeneration.
Journal of Neurology, Neurosurgery & Psychiatry
, 91
(9)
pp. 975-984.
10.1136/jnnp-2020-322987.
|
|
Therriault, J;
Benedet, A;
Pascoal, TA;
Savard, M;
Ashton, N;
Chamoun, M;
Tissot, C;
... Rosa-Neto, P; + view all
(2020)
Determining Amyloid-β positivity using [18F]AZD4694 PET imaging.
The Journal of Nuclear Medicine
10.2967/jnumed.120.245209.
(In press).
|
|
|
Thijssen, EH;
La Joie, R;
Wolf, A;
Strom, A;
Wang, P;
Iaccarino, L;
Bourakova, V;
... Advancing Research and Treatment for Frontotemporal Lobar Degene; + view all
(2020)
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration.
Nature Medicine
, 26
pp. 389-397.
10.1038/s41591-020-0762-2.
|
|
Thomas, MSC;
Ojinaga Alfageme, O;
D'Souza, H;
Patkee, PA;
Rutherford, MA;
Mok, KY;
Hardy, J;
... LonDownS Consortium; + view all
(2020)
A multi-level developmental approach to exploring individual differences in Down syndrome: genes, brain, behaviour, and environment.
Research in Developmental Disabilities
, 104
, Article 103638. 10.1016/j.ridd.2020.103638.
|
|
|
Thompson, PM;
Jahanshad, N;
Ching, CRK;
Salminen, LE;
Thomopoulos, SI;
Bright, J;
Baune, BT;
... ENIGMA Consortium, .; + view all
(2020)
ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries.
Translational Psychiatry
, 10
(1)
, Article 100. 10.1038/s41398-020-0705-1.
|
|
|
Thordardottir, S;
Almkvist, O;
Johansson, C;
Zetterberg, H;
Blennow, K;
Graff, C;
(2020)
Cerebrospinal Fluid YKL-40 and Neurogranin in Familial Alzheimer's Disease: A Pilot Study.
Journal of Alzheimer's Disease
10.3233/JAD-191261.
(In press).
|
|
|
Tible, M;
Sandelius, Å;
Höglund, K;
Brinkmalm, A;
Cognat, E;
Dumurgier, J;
Zetterberg, H;
... Blennow, K; + view all
(2020)
Dissection of synaptic pathways through the CSF biomarkers for predicting Alzheimer's disease.
Neurology
, 95
(8)
e953-e961.
10.1212/WNL.0000000000010131.
|
|
Tijms, BM;
Gobom, J;
Reus, L;
Jansen, I;
Hong, S;
Dobricic, V;
Kilpert, F;
... Visser, PJ; + view all
(2020)
Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics.
Brain
, 143
(12)
pp. 3776-3792.
10.1093/brain/awaa325.
|
|
|
Tjensvoll, AB;
Lauvsnes, MB;
Zetterberg, H;
Kvaløy, JT;
Kvivik, I;
Maroni, SS;
Greve, OJ;
... Omdal, R; + view all
(2020)
Neurofilament light is a biomarker of brain involvement in lupus and primary Sjögren's syndrome.
Journal of Neurology
10.1007/s00415-020-10290-y.
|
|
|
Tjörnstrand, A;
Casar-Borota, O;
Heurling, K;
Schöll, M;
Gjertsson, P;
Himmelman, J;
Itsenko, O;
... Filipsson Nyström, H; + view all
(2020)
Lower 68 Ga-DOTATOC Uptake in Non-Functioning Pituitary Neuroendocrine Tumors Compared to Normal Pituitary Gland - a Proof-of-Concept Study.
Clinical Endocrinology
, 92
(3)
pp. 222-231.
10.1111/cen.14144.
|
|
Tomkins, J;
Ferrari, R;
Vavouraki, N;
Hardy, J;
Lovering, R;
Lewis, P;
McGuffin, L;
(2020)
PINOT: An Intuitive Resource for Integrating Protein-Protein Interactions.
Cell Communication and Signaling
, 18
, Article 92. 10.1186/s12964-020-00554-5.
|
|
Tookey, Sara Angela;
(2020)
Exploring Experiences and Needs of Spousal Carers of People with Behavioural variant Frontotemporal Dementia (BvFTD) including those with Genetic variant FTD (GvFTD): A Qualitative Study.
Doctoral thesis (D.Clin.Psy), UCL (University College London).
|
|
Toombs, J;
Zetterberg, H;
(2020)
In the blood: biomarkers for amyloid pathology and neurodegeneration in Alzheimer's disease.
Brain Communications
, 2
(1)
, Article fcaa054. 10.1093/braincomms/fcaa054.
|
|
|
Toomey, CE;
Heywood, W;
Benson, BC;
Packham, G;
Mills, K;
Lashley, T;
(2020)
Investigation of pathology, expression and proteomic profiles in human TREM2 variant postmortem brains with and without Alzheimer’s disease.
Brain Pathology
10.1111/bpa.12842.
(In press).
|
|
Tortelli, R;
Zecca, C;
Piccininni, M;
Benmahamed, S;
Dell'Abate, MT;
Barulli, MR;
Capozzo, R;
... Logroscino, G; + view all
(2020)
Plasma Inflammatory Cytokines Are Elevated in ALS.
Frontiers in Neurology
, 11
, Article 552295. 10.3389/fneur.2020.552295.
|
|
|
Tsvetanov, KA;
Gazzina, S;
Jones, PS;
van Swieten, J;
Borroni, B;
Sanchez-Valle, R;
Moreno, F;
... Genetic FTD Initiative, GENFI; + view all
(2020)
Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia.
Alzheimer's & Dementia
10.1002/alz.12209.
|
|
|
Tyrberg, T;
Nilsson, S;
Blennow, K;
Zetterberg, H;
Grahn, A;
(2020)
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus.
Journal of NeuroVirology
10.1007/s13365-020-00889-2.
(In press).
|
|
U
|
Utoomprurkporn, N;
Hardy, CJD;
Stott, J;
Costafreda, SG;
Warren, J;
Bamiou, DE;
(2020)
"The Dichotic Digit Test" as an Index Indicator for Hearing Problem in Dementia: Systematic Review and Meta-Analysis.
Journal of the American Academy of Audiology
, 31
(9)
pp. 646-655.
10.1055/s-0040-1718700.
|
V
|
Vallabh, SM;
Minikel, EV;
Williams, VJ;
Carlyle, BC;
McManus, AJ;
Wennick, CD;
Bolling, A;
... Arnold, SE; + view all
(2020)
Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease.
BMC Medicine
, 18
, Article 140. 10.1186/s12916-020-01608-8.
|
|
|
Van der Ende, EL;
Xiao, M;
Xu, D;
Poos, JM;
Panman, JL;
Jiskoot, LC;
Meeter, LH;
... Genetic Frontotemporal Dementia Initiative (GENFI); + view all
(2020)
Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2019-322493.
(In press).
|
|
|
van der Lee, SJ;
Conway, OJ;
Jansen, I;
Carrasquillo, MM;
Kleineidam, L;
van den Akker, E;
Hernández, I;
... Holstege, H; + view all
(2020)
Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.
[Corrigendum].
Acta Neuropathologica
10.1007/s00401-019-02107-8.
(In press).
|
|
|
van Leeuwen, Janneke;
(2020)
Seeing the bigger picture: visual imagination and the social brain.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Vergallo, A;
Lista, S;
Lemercier, P;
Chiesa, PA;
Zetterberg, H;
Blennow, K;
Potier, M-C;
... Alzheimer Precision Medicine Initiative (APMI); + view all
(2020)
Association of plasma YKL-40 with brain amyloid-β levels, memory performance, and sex in subjective memory complainers.
Neurobiology of Aging
, 96
pp. 22-32.
10.1016/j.neurobiolaging.2020.07.009.
|
|
Vermunt, L;
Dicks, E;
Wang, G;
Dincer, A;
Flores, S;
Keefe, SJ;
Berman, SB;
... Dominantly Inherited Alzheimer Network (DIAN); + view all
(2020)
Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer's disease.
Brain Communications
, 2
(2)
, Article fcaa102. 10.1093/braincomms/fcaa102.
|
|
|
Vermunt, L;
Muniz-Terrera, G;
Ter Meulen, L;
Veal, C;
Blennow, K;
Campbell, A;
Carrié, I;
... IMI-EPAD collaborators, .; + view all
(2020)
Prescreening for European Prevention of
Alzheimer Dementia (EPAD) trial-ready
cohort: impact of AD risk factors and
recruitment settings.
Alzheimer's Research & Therapy
, 12
, Article 8. 10.1186/s13195-019-0576-y.
|
|
|
Vicente-Munuera, P;
Burgos-Panadero, R;
Noguera, I;
Navarro, S;
Noguera, R;
Escudero, LM;
(2020)
The topology of vitronectin: A complementary feature for neuroblastoma risk classification based on computer‐aided detection.
International Journal of Cancer
, 146
(2)
pp. 553-565.
10.1002/ijc.32495.
|
|
|
Virhammar, J;
Kumlien, E;
Fällmar, D;
Frithiof, R;
Jackmann, S;
Sköld, MK;
Kadir, M;
... Rostami, E; + view all
(2020)
Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid.
Neurology
10.1212/WNL.0000000000010250.
(In press).
|
|
|
Virhammar, J;
Nääs, A;
Fällmar, D;
Cunningham, JL;
Klang, A;
Ashton, NJ;
Jackmann, S;
... Rostami, E; + view all
(2020)
Biomarkers for CNS injury in CSF are elevated in COVID-19 and associated with neurological symptoms and disease severity.
European Journal of Neurology
10.1111/ene.14703.
(In press).
|
|
|
Vokurka, P;
Barron, A;
Sumaria, S;
Stockford, L;
Jarman, P;
Bhatia, K;
Farmer, S;
... Foltynie, T; + view all
(2020)
Opicapone Efficacy and Tolerability in Parkinson's Disease Patients Reporting Insufficient Benefit/Failure of Entacapone.
Movement Disorders Clinical Practice
10.1002/mdc3.13094.
(In press).
|
|
|
von Euler Chelpin, M;
Söderberg, L;
Fälting, J;
Möller, C;
Giorgetti, M;
Constantinescu, R;
Blennow, K;
... Höglund, K; + view all
(2020)
Alpha-Synuclein Protofibrils in Cerebrospinal Fluid: A Potential Biomarker for Parkinson's Disease.
Journal of Parkinson's Disease
10.3233/JPD-202141.
(In press).
|
|
W
|
Walsh, P;
Sudre, CH;
Fiford, CM;
Ryan, NS;
Lashley, T;
Frost, C;
Barnes, J;
(2020)
CSF amyloid is a consistent predictor of white matter hyperintensities across the disease course from aging to Alzheimer's disease.
Neurobiology of Aging
, 91
pp. 5-14.
10.1016/j.neurobiolaging.2020.03.008.
|
|
Wang, P-N;
Lin, K-J;
Liu, H-C;
Andreasson, U;
Blennow, K;
Zetterberg, H;
Yang, S-Y;
(2020)
Plasma pyroglutamate-modified amyloid beta differentiates amyloid pathology.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 12
(1)
, Article e12029. 10.1002/dad2.12029.
|
|
|
Wefers, AK;
Stichel, D;
Schrimpf, D;
Coras, R;
Pages, M;
Tauziède-Espariat, A;
Varlet, P;
... Capper, D; + view all
(2020)
Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course.
Acta Neuropathologica
, 139
pp. 193-209.
10.1007/s00401-019-02078-w.
|
|
Weil, R;
Reeves, S;
(2020)
Hallucinations in Parkinson’s disease: new insights into mechanisms and treatments.
Advances in Clinical Neuroscience & Rehabilitation
, 19
(4)
pp. 20-22.
10.47795/onns5189.
|
|
|
Weil, R;
Thomas, G;
Leyland, L;
Schrag, A;
Lees, A;
Acosta-Cabronero, J;
(2020)
Brain iron deposition is linked with cognitive severity in Parkinson’s disease.
Journal of Neurology, Neurosurgery, and Psychiatry
, 91
(4)
pp. 418-425.
10.1136/jnnp-2019-322042.
|
|
|
Weil, R;
Zarkali, A;
McColgan, P;
Leyland, L;
Lees, A;
Rees, G;
(2020)
Fibre-specific white matter reductions in Parkinson’s hallucinations and visual dysfunction.
Neurology
, 94
(14)
e1525-e1538.
10.1212/WNL.0000000000009014.
|
|
|
Wentz, E;
Dobrescu, SR;
Dinkler, L;
Gillberg, C;
Gillberg, C;
Blennow, K;
Råstam, M;
(2020)
Thirty years after anorexia nervosa onset, serum neurofilament light chain protein concentration indicates neuronal injury.
European Child & Adolescent Psychiatry
10.1007/s00787-020-01657-7.
|
|
|
Westman, G;
Aurelius, E;
Ahlm, C;
Blennow, K;
Eriksson, K;
Lind, L;
Schliamser, S;
... Studahl, M; + view all
(2020)
Cerebrospinal fluid biomarkers of brain injury, inflammation and synaptic autoimmunity predict long-term neurocognitive outcome in herpes simplex encephalitis.
Clinical Microbiology and Infection
10.1016/j.cmi.2020.09.031.
(In press).
|
|
|
Weston, PSJ;
Poole, T;
Nicholas, JM;
Toussaint, N;
Simpson, IJA;
Modat, M;
Ryan, NS;
... Fox, NC; + view all
(2020)
Measuring cortical mean diffusivity to assess early microstructural cortical change in presymptomatic familial Alzheimer's disease.
Alzheimer's Research & Therapy
, 12
, Article 112. 10.1186/s13195-020-00679-2.
|
|
|
Westwood, S;
Baird, AL;
Anand, SN;
Nevado-Holgado, AJ;
Kormilitzin, A;
Shi, L;
Hye, A;
... Lovestone, S; + view all
(2020)
Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.
Journal of Alzheimer's Disease
10.3233/JAD-190434.
(In press).
|
|
|
Wihersaari, L;
Ashton, NJ;
Reinikainen, M;
Jakkula, P;
Pettilä, V;
Hästbacka, J;
Tiainen, M;
... COMACARE STUDY GROUP; + view all
(2020)
Neurofilament light as an outcome predictor after cardiac arrest: a post hoc analysis of the COMACARE trial.
Intensive Care Medicine
10.1007/s00134-020-06218-9.
|
|
|
Wijeratne, PA;
Johnson, EB;
Eshaghi, A;
Aksman, L;
Gregory, S;
Johnson, HJ;
Poudel, GR;
... Alexander, DC; + view all
(2020)
Robust markers and sample sizes for multi‐centre trials of Huntington's disease.
Annals of Neurology
, 87
(5)
pp. 751-762.
10.1002/ana.25709.
|
|
|
Williams, T;
Houlden, H;
Murphy, E;
John, N;
Fox, NC;
Schott, JM;
Adams, M;
... Lynch, DS; + view all
(2020)
How to diagnose difficult white matter disorders.
Practical Neurology
10.1136/practneurol-2020-002530.
(In press).
|
|
|
Williams, T;
Zetterberg, H;
Chataway, J;
(2020)
Neurofilaments in progressive multiple sclerosis: a systematic review.
Journal of Neurology
10.1007/s00415-020-09917-x.
(In press).
|
|
|
Willumsen, Nanet;
(2020)
Deciphering pathological heterogeneity in familial Alzheimer’s disease.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Woollacott, IOC;
Nicholas, JM;
Heller, C;
Foiani, MS;
Moore, KM;
Russell, LL;
Paterson, RW;
... Rohrer, JD; + view all
(2020)
Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype.
Dementia and Geriatric Cognitive Disorders
, 49
(1)
pp. 56-76.
10.1159/000506282.
|
|
Woollacott, IOC;
Toomey, CE;
Strand, C;
Courtney, R;
Benson, BC;
Rohrer, JD;
Lashley, T;
(2020)
Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration.
Journal of Neuroinflammation
, 17
(1)
, Article 234. 10.1186/s12974-020-01907-0.
|
|
X
|
Xie, C;
Aman, Y;
Adriaanse, BA;
Cader, MZ;
Plun-Favreau, H;
Xiao, J;
Fang, EF;
(2020)
Culprit or Bystander: Defective Mitophagy in Alzheimer's Disease.
Frontiers in Cell and Developmental Biology
, 7
, Article 391. 10.3389/fcell.2019.00391.
|
|
|
Xu, C;
Sellgren, CM;
Fatouros-Bergman, H;
Piehl, F;
Blennow, K;
Zetterberg, H;
Brinkmalm, A;
... Karolinska Schizophrenia Project (KaSP) Consortium, .; + view all
(2020)
CSF levels of synaptosomal-associated protein 25 and synaptotagmin-1 in first-episode psychosis subjects.
IBRO Reports
, 8
pp. 136-142.
10.1016/j.ibror.2020.04.001.
|
|
Y
|
Yan, T;
Liang, J;
Gao, J;
Wang, L;
Fujioka, H;
Alzheimer Disease Neuroimaging Initiative, .;
Zhu, X;
(2020)
FAM222A encodes a protein which accumulates in plaques in Alzheimer's disease.
Nature Communications
, 11
(1)
, Article 411. 10.1038/s41467-019-13962-0.
|
|
|
Yau, WY;
O'Connor, E;
Chen, Z;
Vandrovcova, J;
Wood, NW;
Houlden, H;
(2020)
GGC repeat expansion in NOTCH2NLC is rare in European patients with essential tremor.
Brain
, 143
(7)
e57.
10.1093/brain/awaa144.
|
|
Yau, WY;
Raposo, M;
Bettencourt, C;
Labrum, R;
Vasconcelos, J;
Parkinson, MH;
Giunti, P;
... Houlden, H; + view all
(2020)
The repeat variant in MSH3 is not a genetic modifier for spinocerebellar ataxia type 3 and Friedreich's ataxia.
Brain
, 143
(4)
e25.
10.1093/brain/awaa043.
|
|
Yau, WY;
Sullivan, R;
Chen, Z;
Lynch, DS;
Vandrovcova, J;
Wood, NW;
Houlden, H;
(2020)
GGC Repeat Expansion in NOTCH2NLC is rare in European Leukoencephalopathy.
Annals of Neurology
, 88
(3)
pp. 641-642.
10.1002/ana.25818.
|
|
Yau, WY;
Vandrovcova, J;
Sullivan, R;
Chen, Z;
Zecchinelli, A;
Cilia, R;
Stefano, D;
... Houlden, H; + view all
(2020)
Low Prevalence of NOTCH2NLC GGC Repeat Expansion in White Patients With Movement Disorders.
Movement Disorders
10.1002/mds.28302.
(In press).
|
|
|
Yong, KXX;
McCarthy, ID;
Poole, T;
Ocal, D;
Suzuki, A;
Suzuki, T;
Mengoudi, K;
... Crutch, SJ; + view all
(2020)
Effects of lighting variability on locomotion in posterior cortical atrophy.
Alzheimer's & Dementia: Translational Research & Clinical Interventions
, 6
(1)
, Article e12077. 10.1002/trc2.12077.
|
|
|
Young, Alexandra L;
Bocchetta, Martina;
Cash, David M;
Convery, Rhian S;
Moore, Katrina M;
Neason, Mollie R;
Thomas, David L;
... Rohrer, Jonathan D; + view all
(2020)
Subtype and stage inference identifies distinct atrophy patterns in genetic frontotemporal dementia that MAP onto specific
MAPT
mutations.
Presented at: UNSPECIFIED.
|
|
Young, Alexandra L;
Bocchetta, Martina;
Cole, James;
Williams, Steven CR;
Rohrer, Jonathan D;
Alexander, Daniel C;
(2020)
Characterising the spatiotemporal heterogeneity of neurodegenerative diseases using subtype and stage inference.
Presented at: UNSPECIFIED.
|
|
Young, PNE;
Estarellas, M;
Coomans, E;
Srikrishna, M;
Beaumont, H;
Maass, A;
Venkataraman, AV;
... Schöll, M; + view all
(2020)
Imaging biomarkers in neurodegeneration: current and future practices.
Alzheimer's Research & Therapy
, 12
, Article 49. 10.1186/s13195-020-00612-7.
|
|
Z
|
Zarkali, A;
McColgan, P;
Leyland, L-A;
Lees, AJ;
Weil, RS;
(2020)
Visual dysfunction predicts cognitive impairment and white matter degeneration in Parkinson's disease.
BioRxiv: Cold Spring Harbor, NY, USA.
|
|
Zarkali, A;
McColgan, P;
Ryten, M;
Reynolds, R;
Leyland, L;
Lees, A;
Rees, G;
(2020)
Dementia risk in Parkinson’s disease is associated with
interhemispheric connectivity loss and determined by regional
gene expression.
NeuroImage: Clinical
, 28
, Article 102470. 10.1016/j.nicl.2020.102470.
|
|
|
Zarkali, A;
McColgan, P;
Ryten, M;
Reynolds, R;
Leyland, L;
Lees, A;
Rees, G;
(2020)
Differences in network controllability and regional gene expression underlie visual hallucinations in Parkinson’s disease.
Brain: a journal of neurology
, 143
(11)
pp. 3435-3448.
10.1093/brain/awaa270.
|
|
|
Zetterberg, H;
Alawode, D;
Keshavan, A;
o'connor, A;
Weston, P;
Paterson, R;
Heslegrave, A;
... Schott, J; + view all
(2020)
Blood Tests for Alzheimer Disease.
Practical Neurology
|
|
|
Zetterberg, H;
(2020)
Is There a Value of Neurofilament Light as a Biomarker for Neurodegeneration in Parkinson's Disease?
Movement Disorders
, 35
(7)
pp. 1111-1112.
10.1002/mds.28101.
|
|
Zetterberg, H;
(2020)
Neurofilament light in blood - What more is needed for clinical implementation in multiple sclerosis?
EBioMedicine
, 57
, Article 102826. 10.1016/j.ebiom.2020.102826.
|
|
Zetterberg, H;
(2020)
Plasma neurofilament light in progressive multiple sclerosis.
[Editorial comment].
Acta Neurologica Scandinavica
, 141
(1)
pp. 14-15.
10.1111/ane.13184.
|
|
Zetterberg, H;
Bendlin, BB;
(2020)
Biomarkers for Alzheimer's disease—preparing for a new era of disease-modifying therapies.
Molecular Psychiatry
10.1038/s41380-020-0721-9.
(In press).
|
|
Zetterberg, H;
Blennow, K;
(2020)
Blood Biomarkers: Democratizing Alzheimer's Diagnostics.
Neuron
, 106
(6)
pp. 881-883.
10.1016/j.neuron.2020.06.004.
|
|
Zhang, D;
Guelfi, S;
Garcia-Ruiz, S;
Costa, B;
Reynolds, RH;
D’Sa, K;
Liu, W;
... Ryten, M; + view all
(2020)
Incomplete annotation has a disproportionate impact on our understanding of Mendelian and complex neurogenetic disorders.
Science Advances
, 6
(24)
, Article eaay8299. 10.1126/sciadv.aay8299.
|
|
|
Zhang, R;
Song, J;
Isgren, A;
Jakobsson, J;
Blennow, K;
Sellgren, CM;
Zetterberg, H;
... Landén, M; + view all
(2020)
Genome-wide study of immune biomarkers in cerebrospinal fluid and serum from patients with bipolar disorder and controls.
Translational Psychiatry
, 10
, Article 58. 10.1038/s41398-020-0737-6.
|
|
|
Zhou, H;
Meng, J;
Malerba, A;
Catapano, F;
Sintusek, P;
Jarmin, S;
Feng, L;
... Muntoni, F; + view all
(2020)
Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy.
Journal of Cachexia, Sarcopenia and Muscle
10.1002/jcsm.12542.
(In press).
|
|
Zhou, X;
Chen, Y;
Ip, FCF;
Lai, NCH;
Li, YYT;
Jiang, Y;
Zhong, H;
... Ip, NY; + view all
(2020)
Genetic and polygenic risk score analysis for Alzheimer's disease in the Chinese population.
Alzheimers Dement (Amst)
, 12
(1)
, Article e12074. 10.1002/dad2.12074.
|
|
|
Zimmerer, V;
Hardy, C;
Eastman, J;
Dutta, S;
Varnet, L;
Bond, R;
Russell, L;
... Varley, R; + view all
(2020)
Automated profiling of spontaneous speech in primary progressive aphasia and behavioral-variant frontotemporal dementia: An approach based on usage-frequency.
Cortex
, 133
pp. 103-119.
10.1016/j.cortex.2020.08.027.
|
Å
|
Åberg, ND;
Wall, A;
Anger, O;
Jood, K;
Andreasson, U;
Blennow, K;
Zetterberg, H;
... Svensson, J; + view all
(2020)
Circulating levels of vascular endothelial growth factor and post-stroke long-term functional outcome.
Acta Neurologica Scandinavica
10.1111/ane.13219.
(In press).
|
|
